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The chronically stressed individual 
goes through three stages: 
Alarm 
Resistance 
And exhaustion 
 
(Dabney M. Ewin 2009)  
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Preface 
The relation between symptoms and objective measures of disease severity has fascinated me 
since medical school. I therefore as a first year medical student tried to convince the dean of 
the Faculty of Medicine at the University of Bergen to conduct more research on the subject. I 
do not know the result of this talk, but personally I postponed clinical specialization when I 
was offered a PhD grant concerning psychosomatic aspects of obstructive sleep apnea (OSA).  
In close dialogue with my main supervisor, associate professor Toril Dammen, my co-
supervisor, Professor Inger Hilde Nordhus and Professor Knut Stavem I wrote a research protocol 
titled “psychosomatic aspects of obstructive sleep apnea syndrome”. Research questions formulated 
addressed relations between perceived symptoms, psychiatric disorders, neuropsychological tests and 
objective measures of OSA. In addition I wanted to assess properties of standardized, self-reporting 
questionnaires in a community-based sample consisting of participants with high risk for OSA. 
Finally, I described aims of studying aspects of health related quality of life, illness perception and 
perceived sleep quality in all participants of the Akershus Sleep Apnea Project (ASAP). However, 
because the appointed author of the reference article of the ASAP withdrew, I was requested to write 
this article. Thus, this thesis address more epidemiological aspects of OSA than initially planned but 
unfortunately less health related quality of life, illness behavior and perceived sleep quality.  
When I now, almost seven years later, conclude this phase of my life, I am urged to 
acknowledge my wife and children for their support and endurance. I am also grateful for the 
opportunity to learn from my fantastic supervisor, Toril Dammen, my co-supervisor professor 
Inger Hilde Nordhus, Professor Torbjørn Omland and Professor Torbjørn Moum. In addition 
to persons acknowledged alphabetically below, I will in particular emphasize the close and 
vital collaboration with my fellow PhD-students, Gunnar Einvik, Anna Randby and Silje 
Kjeka Namtvedt. I will also in particular acknowledge Professor Kari Kværner who initiated 
the project and Professor Michael Bjørn Russell, Professor Pål Guldbrandsen, Professor Kari 
Almendingen and Harriet Akre who all intervened in critical times. A final acknowledgement 
goes to all participants included in the ASAP and to other PhD-students, senior researchers, 
research nurses and administrative staff at the Department of Behavioral Sciences in Medicine 
at the University of Oslo and at Akershus University Hospital that have been involved in the 
project.  
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Summary 
Background: The cardinal symptoms of Obstructive sleep apnea (OSA) are snoring or 
gasping while sleeping and sleepiness or fatigue while awake. In addition, OSA is associated 
with obesity and hypertension. Accordingly, several screening questionnaires based on self-
reported symptoms, obesity and/or hypertension have been developed. Among these, the 
Berlin Questionnaire (BQ) was most thoroughly validated when planning this thesis. 
However, no study of the properties of the BQ or other screening questionnaire for OSA had 
been conducted in a community-based setting. Furthermore, neither the overall prevalence of 
OSA nor gender specific prevalences of OSA had previously been estimated in a Norwegian 
general population sample. 
In addition to cardinal symptoms, obesity and hypertension, OSA has been associated 
with impaired cognitive function, anxiety, somatoform pain and depression in numerous 
clinical studies. However, associations observed in clinical populations can be related to the 
patophysiology of the target disorder, to health seeking behavior of the sub-population 
seeking treatment as well as to local referral practice. Thus, associations between impaired 
cognitive function, anxiety, somatoform pain, depression and OSA should also be studied in 
community-based samples consisting of persons previously not seeking- or being referred to 
treatment for OSA.  
Community-based studies prior to this thesis have supported patophysiological 
relations between OSA, snoring, hypertension and obesity. On the other hand, previous 
community-based studies of associations between OSA and cognitive impairments or 
symptoms of psychiatric disorders either suffered from methodological limitations such as 
self-report of psychiatric symptoms, self-report of OSA/lack of respiratory variables or they 
reported inconsistent results. Thus, more studies conducted in community-based samples that 
assess respiratory variables and properly diagnosed co-morbid disorders were warranted. 
Furthermore, levels of neurocognitive function and prevalences of psychiatric disorders in a 
community-based BQ high risk sample were not known. Thus the aims of this thesis are:  
Paper I: 
x To evaluate screening properties of the BQ in a Norwegian, general population  
based sample 
x To estimate overall, age and gender specific prevalences of OSA in a 
Norwegian general population based sample using polysomnography with 
 cutoff values of 5 and 15 on the apnea hypopnea index (AHI) as reference 
standards. 
Paper II: 
x To characterize cognitive function in a community-based high risk population 
for OSA. 
x To investigate associations between verbal memory, executive function and 
OSA severity as assessed by the AHI, indicators of oxygen saturation and the 
arousal index before and after adjustment for putative confounders such as age, 
gender, co-morbid conditions (alcohol abuse, asthma), use of hypnosedatives, 
sleepiness, smoking and educational level. 
Paper III:  
x To estimate the prevalence of current psychiatric disorders in community-
dwelling adults at a high risk for OSA, as identified by the BQ.  
x To explore associations between OSA and current psychiatric disorders 
unadjusted and adjusted for putative confounders (demographic factors (age, 
sex, higher education and co-habitation) or established predictors for OSA as 
assessed by the BQ.  
 
Material and methods: The source population of this thesis is the participants in the 
Akershus Sleep Apnea Project. The BQ was distributed to 30,000 community-dwelling adults 
aged 30-65 years by mail in February 2006. The clinical data in the ASAP was collected from 
535 respondents of the BQ that agreed to undergo a comprehensive medical examination with 
overnight, in-hospital polysomnography in the period between June 2006 and January 2008. 
The scoring manual for the BQ defines high risk for OSA as any combination of daytime 
somnolence, snoring and hypertension or obesity. Thus, community-dwelling adults with high 
risk of OSA in this thesis all have combinations of two or three of these symptom categories. 
Paper II and III are based on a sub sample of 290 consecutively included BQ high risk 
participants. The median AHI in this clinical sample was 7.7 (25th percentile 2.4, 75th 
percentile 22.2). In addition, paper III comprises an auxiliary sample consisting of all 157 age 
and gender stratified BQ low risk participants included in the ASAP. 
Verbal memory was assessed by the Rey Auditory Learning Test (RAVLT) and 
Executive function was assessed by the Stroop test. Psychiatric disorders were diagnosed with 
the structured clinical interview for axis I disorders (SCID-I) according to the Diagnostic and 
Obstructive Sleep Apnea in Community-Dwelling Adults  
13 
 
Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Symptoms of depression were 
assessed by the Beck Depression Inventory (BDI). 
Results: Results are presented in three papers. The main findings of the first paper were that 
one out of four middle-aged Norwegians were classified to be at risk of having OSA. 
However, the diagnostic properties of the questionnaire were sub-optimal when used as a 
screening tool for OSA in the general population. The prevalence estimates of OSA in a 
Norwegian general population were in line with almost 20 years old US estimates.  
The main finding of paper II was that persons with high risk for OSA had cognitive 
test scores similar to persons 20-30 years older in normative samples. Mean cognitive scores 
of both verbal memory and executive function declined significantly when categorized by 
tertiles of OSA severity as assessed by the AHI, nadir oxygen saturation, mean oxygen 
saturation, the oxygen desaturation index and percentage time below 90% oxygen saturation 
in unadjusted analyses. The arousal index was not related to any cognitive test scores. After 
adjusting for putative confounders, only mean oxygen saturation during sleep remained 
independently associated with the RAVLT scores.  
The main finding of paper III was that major depressive disorder, current anxiety and 
somatoform pain disorder were diagnosed in 12.4%, 14.8% and 19.3% of participants, 
respectively. At least one psychiatric disorder was diagnosed in 110 (37.9%) participants. 
Prevalences of psychiatric disorders did not differ significantly between high risk participants 
with and without OSA. The odds ratio of participants with OSA for having a psychiatric 
disorder compared with participants without was 0.54 (95% CI = 0.33–0.88). However, a 
negative association did not persist in the auxiliary sample. 
Conclusions: The BQ had sub-optimal screening properties for OSA when distributed by 
mail to a general population sample. Moreover, estimated prevalences of OSA were 
comparable to more than 20 year old US estimates. Furthermore, the findings of mild 
impaired cognitive function and the findings that high prevalences of psychiatric disorders 
within a community based high risk population are novel in the OSA literature.  
Regarding associations between OSA, cognitive function and psychiatric disorders, 
the independent positive relation found between average oxygen saturation and verbal 
memory strengthens and extends previous findings from clinical samples. However, previous 
findings of associations between OSA and anxiety or depression could not be reproduced in 
our study.  
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1.0.0 Background 
 
1.1.0 The patient with obstructive sleep apnea 
1.1.1 History  
In Charles Dickens first novel, “The Pickwick Papers”, the servant “Joe” is initially described 
as: “a fat and red-faced boy, in a state of somnolency” (Dickens 1836). The boy’s state of 
somnolence is further portrayed: “The fat boy rose, opened his eyes, swallowed the huge 
piece of pie he had been in the act of masticating when he last fell asleep, and slowly obeyed 
his master’s orders”.  
“The Pickwick syndrome” was introduced as a clinical syndrome by Sir William Osler 
in 1918. The syndrome originally included obesity, hypersomnolence, periodic breathing with 
hypoventilation and cor pulmonale (Guilleminault et al. 1976). The name of the syndrome 
was inspired by Dickens description of the fat boy Joe. In 1965, Gastaut, Tassinari and Duron 
introduced sleep studies in the research on sleep related breathing and Pickwick syndrome 
(Guilleminault et al. 1976). After this shift of focus, new pathological mechanisms were 
identified. One of these mechanisms was mechanical obstruction of the upper airways during 
inspiration. After a consensus conference in 1972, the term “obstructive sleep apnea 
syndrome” was introduced by Guilleminault, Tilkian and Dement (Guilleminault et al. 1976). 
The introduction of obstructive sleep apnea syndrome thus opened for a more nuanced 
understanding of sleep disordered breathing beyond the original “Pickwick syndrome”.   
1.1.2 Diagnosis of obstructive sleep apnea (OSA)  
In the International Classification of Sleep Disorders, second edition (ICSD-2) (American 
Academy of Sleep Medicine 2005), the terminology OSA “syndrome” was abandoned. The 
other major change in the ICSD-2 compared to previous diagnostic requirements for OSA was 
that daytime symptoms were not required for a diagnosis of OSA in persons with an apnea 
hypopnea index (AHI) of 15 or more. The ICSD-2 diagnostic criteria for OSA are listed in 
Table 1.  
 
  
 Table 1. International Classification of Sleep Disorders, second edition. Diagnostic 
criteria of OSA 
 
A, B, and D or C and D satisfy the criteria:  
A: At least one of the following applies:  
x The patient complains of unintentional sleep episodes during wakefulness, daytime 
sleepiness, unrefreshing sleep, fatigue or insomnia 
x The patient wakes with breath holding, gasping, or choking 
x The bed partner reports loud snoring, breathing interruptions, or both during the 
patient’s sleep 
B: Polysomnographic recording shows the following:  
x Five or more scoreable respiratory events (i.e., apneas, hypopneas, or respiratory 
related arousals) per hour of sleep 
x Evidence of respiratory effort during all or a portion of each respiratory event (In the 
case of a respiratory related arousal, this is best seen with the use of esophageal 
manometry) 
C: Polysomnographic recording shows the following:  
x Fifteen or more scoreable respiratory events (i.e., apneas, hypopneas, or respiratory 
related arousals)  
x Evidence of respiratory effort during all or a portion of each respiratory event (In the 
case of a respiratory related arousal, this is best seen with the use of esophageal 
manometry) 
D: The disorder is not better explained by another current sleep disorder, medical or 
neurological disorder medication use, or substance use disorder. 
 
 
Readers of the current literature will also encounter the term “sleep disordered 
breathing” which is not mentioned in the ICSD-2. Instead, the term “sleep related breathing 
disorders” is described, which is a broader definition than OSA also comprising central sleep 
apnea, obesity hypoventilation (former “Pickwick syndrome”) and upper airway resistance 
syndrome (American Academy of Sleep Medicine 2005). The spectrum of sleep related 
breathing disorders is illustrated in Figure 1 (modified from (Banno and Kryger 2007)).  
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Figure 1: The spectrum of sleep related breathing disorders (adapted and modified from 
Banno and Kryger.) 
 
Severe      Physiologic abnormality Consequences
      Morbid obesity  Cor pulmonale 
      Awake hypoventilation Erythrocytosis 
 
     Apneas and hypopneas Cardiovascular  
Hypoxemia   disorders1 
          Impaired cognition2 
          Depression3  
      Increased arousals  Daytime sleepiness 
 
      Increased upper airway Snoring 
Mild      resistance 
 
1-3 = Modifications from the original figure. (1=(Somers et al. 2008), 2 =(Aloia et al. 2004), 
3= (Harris et al. 2009)) 
 
Blood samples and respiratory effort related arousals necessary to diagnose obesity 
hypoventilation (Pickwick) syndrome and upper airway resistance syndrome respectively are 
usually not registered in routine clinical practice.  
1.1.3 OSA severity 
Also within OSA, there is a severity spectrum based on objective findings and symptom 
report. Objective findings have traditionally been categorized as mild OSA (AHI 5-15), 
moderate OSA (AHI 15-30) and severe OSA (AHI >30) (American Academy of Sleep 
Medicine 1999). However, because the length of apneas and hypopneas are mediated by 
complex regulation involving anatomy, ventilatory stability, end expiratory lung volume, 
arousal threshold and upper airway muscle control (Saboisky et al. 2009;White 2005), also 
variables assessing oxygen saturation and number of arousals are of value when categorizing 
objective findings. Subjective symptom report in OSA is discussed in detail below.  
Obesity Hypoventilation syndrome 
Obstructive Sleep Apnea 
Upper airway resistance syndrome 
Asymptomatic snorer 
 1.1.4 Treatment of patients with OSA 
In the 1970’s the treatment of choice for OSA was tracheotomy. Thus, because of the severe 
side effects of this treatment, most patients treated probably had severe OSA defined both by 
the AHI and symptom report (Guilleminault et al. 1976). Now, 40 years later, patients with 
considerably less severe OSA are treated with less invasive methods. The treatments of choice 
are lifestyle modification (Shneerson and Wright 2001) followed by continuous positive 
airway pressure (CPAP) treatment during sleep (Giles et al. 2006;White et al. 2001). 
However, compliance with CPAP treatment is often poor, with up to 70% of patients quitting 
treatment (Lindberg et al. 2006). Therefore, oral devices (Lim et al. 2004) or surgery 
(Bridgman et al. 1998) often are considered in addition to or instead of CPAP.  
The main reasons for treating patients with OSA are relief of daytime symptoms and 
reduction of risk for traffic accidents (Krieger et al. 2002), cardiovascular disease (Yaggi et 
al. 2005) and death (Punjabi et al. 2009;Young et al. 2008). However, daytime symptoms in 
some patients remain after treatment (Giles et al. 2006;White et al. 2001). Moreover, 
reduction of risk for hypertension has been reported to occur only in symptomatic OSA 
(Kapur et al. 2008). Thus, clinicians identifying and treating OSA need a broad understanding 
of the interplay between daytime symptoms, OSA severity and co-morbid disorders. This 
thesis aims to expand knowledge of this interplay in a community-based sample.    
 
1.2.0 Epidemiology and OSA 
In 1946 Joseph Berkson asserted: “Various circumstances, such as the severity of the 
symptoms, the amenability for the disease to treatment by a local physician or the reputation 
of a particular hospital for treatment of particular diseases will determine the probability that a 
specific disease will bring its victim to a particular hospital” (Berkson 1946). Berksons 
statement, which is known as Berksons Bias, implies that relations between any disorder and 
symptoms observed in a clinical population can both be related to the patophysiology of the 
disorder and to features related to behavior of the sub-population seeking treatment and those 
who refer for treatment.  
Regarding OSA, these “various circumstances” can be perception of symptoms such 
as daytime sleepiness or fatigue and observations of apneas or hypopneas during sleep from 
bed partners. Thus, in addition to the utility of evaluating screening instruments for OSA and 
estimating the prevalence of OSA in the general population, epidemiological-clinical studies 
are suitable for assessing relations initially observed in clinical samples when these “various 
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circumstances” are not present. Therefore, the replication of clinically observed relations in 
community-based samples strengthens the probability of a true relation.    
1.2.1 Screening for OSA 
A brief, fast track publication in 1997 resulted in a massive focus on screening for OSA 
(Young et al. 1997). Terry Young and colleagues estimated that 93% of women and 82% of 
men with moderate to severe OSA in the general population were undiagnosed (Young et al. 
1997). This finding contributed to a rapid growth in clinical recognition of OSA among 
previously undiagnosed persons worldwide (Kapur et al. 2002;Young 2009). Clinical 
recognition of OSA is important because with proper treatment, the risk for traffic accidents 
(Krieger et al. 2002), cardiovascular disease (Yaggi et al. 2005) and death (Punjabi et al. 
2009;Young et al. 2008) has been shown to decrease. 
Several questionnaires have been developed in order to identify persons at risk for 
OSA (Harding 2001;Pang and Terris 2006;Rowley et al. 2000). Such questionnaires evaluate 
the risk for OSA based on self-report of symptoms and/ or features of OSA. High risk for 
OSA based on these questionnaires has often been used as a substitute for a diagnosis of OSA 
in community-based studies (Harding 2001). However, none of these questionnaires had been 
validated in a general population based sample prior to the planning of this thesis.  
After reviewing the literature, the Berlin Questionnaire (BQ) (Netzer et al. 1999) was 
identified as the most promising questionnaire when screening for OSA in the general 
population. The BQ was developed based on consensus, was in frequent clinical use, and had 
been used to assess the risk of OSA in several clinical and non-clinical samples (Gassino et al. 
2005;Moreno et al. 2004;Mustafa et al. 2005;Principe-Rodriguez et al. 2005;Singh et al. 
2005). In addition, by 2005 the BQ was the only screening instrument for OSA that had been 
validated in both a general practice and a hospital setting (Gami et al. 2004;Netzer et al. 
1999). Screening properties of the BQ across various samples are displayed in Table 2. I have 
identified 9 studies of BQ properties that have been published after the planning of this thesis 
(Ahmadi et al. 2008;Chung et al. 2008;Gantner et al. 2010;Gus et al. 2008;Sert Kuniyoshi et 
al. 2011;Sharma et al. 2006;Thurtell et al. 2011;Vaz et al. 2011;Weinreich et al. 2006).    
 
 Table 2: Studies of screening properties of the Berlin Questionnaire 
Author Year Setting Sensi- 
tivity 
Speci-
ficity 
Diagnostic 
criteria 
Netzer, N.C. 1999 General practice 0.86 0.77 AHI >5 
Gami, A.S. 2004 Cardiology outpatient 0.86 0.89 AASM 1999 
Studies published after the planning of this study 
Sharma, S.K. 2006 Unclear 0.86 0.95 AHI ≥5 
Weinreich, G. 2006 Pulmonology 
rehablilitation 
0.63 0.54 AHI >10 
Gus, M. 2008 Cardiology outpatient 0.86 0.65 AHI ≥10 
Chung, F 2008 Surgical 0.69 0.56 AHI >5 
Ahmadi, N. 2008 Sleep clinic 0.68 0.49 AHI >5 
Gantner, D 2010 General population with 
high cardiovascular risk  
0.89 0.35 AHI ≥15 
Vaz, A.P. 2011 Sleep clinic 0.72 0.50 AHI >5 
Thurtell, MJ 2011 Ophtalmology clinic 0.83 0.58 AHI ≥5 
Kuniyoshi, FH 2011 MI survivors 0.68 0.34 AHI ≥5 
  
AASM 1999 = American Academy of Sleep Medicine report from 1999 with suggested 
diagnostic criteria for OSA that later have been incorporated in the International 
Classification of Sleep Disorders, second edition reported in Table 1. MI = Myocardial 
Infarction 
 
The BQ identifies risk of OSA based on self-reported snoring, daytime somnolence 
and established obesity/ hypertension. General population prevalence estimates of these 
symptoms and/ or features of OSA had been published prior to the planning of this thesis: 
Regular snoring was reported to occur in 40% of the UK adult population while self-reported 
apneas occurred in 3.8% (Ohayon et al. 1997). In Denmark, habitual snoring has been 
reported to occur in 19.1% of adult males and 7.9% of adult females (Jennum and Sjol 1993). 
Norwegian prevalence estimates for snoring and self- reported apneas could not be identified. 
In Norway, obesity (Body mass index (BMI) > 30 kg m-2) was estimated to be present in 23% 
of adults > 16 years of age in 2002 (www.ssb.no). Self-reported hypertension had been 
reported in 11,7% of respondents in a large, Norwegian community-based study (Hallan et al. 
2003). Regarding daytime symptoms of OSA, excessive daytime sleepiness (EDS) defined by 
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a cut-off on the Epworth Sleepiness Scale (ESS) of more than 10 had been estimated to affect 
5.9% of the Australian general adult population (Johns 1991). Norwegian general population 
estimates of EDS were not identified prior to the planning of this thesis. 
 The main quality measures of a screening instrument are sensitivity and specificity 
which are measures of the proportions of “true positive” and “true negative” cases 
respectively (Knottnerus J.A 2002). The ideal screening instrument thus has both sensitivity 
and specificity of 100%. However, because no screening instrument is ideal and because 
prevalence of the features used for screening vary between source populations, there will 
always be screening positive subjects without the target disorder (false positive) and screening 
negative subjects with the target disorder (false negative) (Knottnerus J.A 2002). On the other 
hand, I have not identified specific minimum criteria of a screening instrument for OSA. 
However, it is recommended that prediction models for OSA should have high sensitivity so 
as not to miss true positives, while a low specificity is rather typical and less problematic 
(Harding 2001).   
1.2.2 Prevalence estimates and incidence of OSA  
The first large- scale community-based studies of OSA were published in the late 1980’s and 
the 1990’s (Bearpark et al. 1995;Bixler et al. 1998;Bixler et al. 2001;Duran et al. 
2001;Gislason et al. 1988;Jennum and Sjol 1992;Young et al. 1993). The most commonly 
cited prevalence estimate of OSA in the general population, defined as the occurrence of five 
or more apneas or hypopneas per hour, was 24% in males and 9% in females recruited from a 
US working population (Young et al. 1993). When OSA was defined as AHI ≥ 5 and daytime 
sleepiness (Criterion A and B, table 1), the prevalence was estimated to be 2% for females 
and 4% for males (Young et al. 1993). Thus, methodological differences in characterizing 
OSA have impact on the prevalence estimates. Moreover, gender, age, obesity, smoking, 
alcohol and ethnicity are all factors that influence the prevalence of OSA (Lindberg and 
Gislason 2000).  
In Scandinavia, a Swedish study from 1989 estimated a prevalence of OSA (defined 
by sleepiness and AHI ≥ 5) of 1.3% in males which is considerably lower than the later US 
estimates (Gislason et al. 1988). A Danish study from 1992 estimated a prevalence of 10.9% 
for males and 6.3% for females when OSA was defined by AHI ≥ 5 (Jennum and Sjol 1992). 
When hypersomnia was added to these criteria, the estimates were 0.9% for females and 1.9% 
for males. Prevalence estimates of OSA in this age group from northern Europe after 1992 
had not been identified when this thesis was planned. Neither the total prevalence nor age- 
 and sex specific prevalences for OSA have previously been estimated in a Norwegian general 
population based sample.  
The 5-year incidence of OSA has been estimated to be 7.5% for moderately severe 
OSA and 16% for mild to moderate OSA (Tishler et al. 2003). Disease progression over time 
has also been reported in a Swedish cohort (Lindberg et al. 1999).  
1.2.3 A clinical-epidemiological approach to clinically suggested associations 
Prior to the planning of this thesis, most community-based studies of relations between OSA 
and cardinal symptoms (snoring and daytime sleepiness) had supported a causal relation 
between self-reported snoring or gasping and OSA (Bearpark et al. 1995;Young et al. 2002b). 
On the other hand, the theroretical concept of sleepiness is complex and disputed (Cluydts et 
al. 2002). A community-based study published in 2005 also reported that depression was the 
most significant risk factor for EDS followed by body mass index, age, typical sleep duration, 
diabetes, smoking, and finally OSA (Bixler et al. 2005).   
In addition to cardinal symptoms, community-based studies of relations between OSA 
and obesity, hypertension, and cardiovascular morbidity also had supported previous findings 
of positive associations prior to this thesis (Young et al. 2002a). However, community-based 
studies of relations with neurocognitive impairment (Berry et al. 1987;Boland et al. 
2002;Hayward et al. 1992;Kim et al. 1997;Telakivi et al. 1988) and symptoms of psychiatric 
disorders (Enright et al. 1996;Kripke et al. 1997;Ohayon 2003) either suffered from 
methodological limitations or reported inconsistent findings. It was therefore decided to 
specifically focus on cognitive function and co-morbid psychiatric disorders in this study.  
OSA and cognitive function 
Neurocognitive function consists of basal processes (i.e. attention, motor speed and vigilance) 
and more differentiated cognitive functions, of which impairments in verbal memory 
(Naegele et al. 2006;Twigg et al. 2010) and executive function (Verstraeten et al. 2004) have 
been found to be most strongly related to OSA. Prior to the planning of this thesis, studies 
based on clinical samples had indicated an association between moderate to severe OSA and 
impaired cognitive function (Aloia et al. 2004;Beebe et al. 2003;Decary et al. 2000;Engleman 
and Joffe 1999;Verstraeten and Cluydts 2004). I identified five community-based studies 
(Berry et al. 1987;Boland et al. 2002;Hayward et al. 1992;Kim et al. 1997;Telakivi et al. 
1988) and two studies of mild OSA in volunteers (Adams et al. 2001;Redline et al. 1997) that 
had assessed cognitive function with rater-administered instruments in addition to objective 
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sleep measures prior to this thesis. I also identified a Scandinavian community-based study 
that assessed cognitive function by self-report (Jennum and Sjol 1994). Three of the identified 
studies reported analyses by variables assessing oxygen saturation (4% oxygen desaturation 
index, lowest oxygen saturation or percentage time below 90% oxygen saturation (Adams et 
al. 2001;Boland et al. 2002;Telakivi et al. 1988)). In these studies, the associations with 
oxygen saturation were at least as strong as the associations reported between cognitive 
functions and measures of apneas and hypopneas. Accordingly, there was a need for further 
studies of the relations between cognitive function and OSA severity as assessed by the AHI, 
indicators of oxygen saturation and the arousal index. 
Affected cognitive domains in previous community-based studies are verbal memory 
(Wechsler Memory Scale (Telakivi et al. 1988), declarative memory factor (Adams et al. 
2001)), working memory (composite factor (Adams et al. 2001)), spatial orientation (Clock 
Test (Telakivi et al. 1988)), executive function (Wechsler Adult Intelligence Scale-Revised 
Digits Backward Subtest (Redline et al. 1997)) and cerebral efficiency (composite factor 
(Hayward et al. 1992)).  
Finally, previous community based studies have only to a minor extent been able to 
control for putative confounders of the relation between cognitive impairment and OSA, such 
as sociodemography, alcohol abuse, sleepiness, use of hypnosedatives, smoking and asthma 
(Adams et al. 2001;Boland et al. 2002;Kim et al. 1997;Redline et al. 1997). Because such 
factors are likely to be related both to cognitive function and to OSA, control of such putative 
confounders are warranted in community-based studies of this relation (Saunamaki and 
Jehkonen 2007a).  
OSA and psychiatric disorders  
In several studies of clinical populations, OSA has been linked to symptoms of psychiatric 
disorders such as depression, mania, anxiety, psychosis, hypochondriasis and somatization 
(Aikens and Mendelson 1999;Bardwell et al. 1999;Kales et al. 1985;Sharafkhaneh et al. 
2005). However, as explained above, such associations may be overestimated in clinical 
samples because of selection to hospitals by “various circumstances” (Berkson 1946). Thus, 
regarding OSA, persons who experience daytime sleepiness or fatigue and persons with 
spouses that observe apneas or hypopneas during sleep will presumably be more likely to seek 
help and thus be referred to OSA evaluation than others. The effect of such selection 
presumably leads to a higher proportion of undiagnosed OSA among persons without daytime 
symptoms or living alone. It was reported prior to the planning of this thesis that daytime 
 sleepiness is more strongly related to depression than to OSA (Bixler et al. 2005). Moreover, 
the effect of shared risk factors had been postulated to affect the relation between depression 
and OSA (Andrews and Oei 2004). The effect of shared risk factors thus is a limitation to 
studies of this relation when one relies on self-reports of previously diagnosed OSA. For 
example, Ohayon’s findings from 2003 (Ohayon 2003), where 17.6% of adults in the general 
population with self-reported OSA in a telephone interview were diagnosed with co-morbid 
depression, could have been affected by such selection. A community-based study that 
assessed both OSA and psychiatric disorders with proper diagnostic tools was therefore 
warranted (Saunamaki and Jehkonen 2007b). 
The general prevalence of major depressive disorder in the Norwegian general 
population has been estimated to be 7.3% (Kringlen et al. 2001). The Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for major depressive 
disorder (MDD) are displayed in appendix 1.  
In addition to the abovementioned study by Ohayon, we identified two other 
community-based studies of the relation between OSA and depression (Enright et al. 
1996;Kripke et al. 1997). The study by Kripke et al. reported no relation (Kripke et al. 1997) 
and the study by Enright et al reported a gender- specific relation (i.e. an association among 
women) (Enright et al. 1996). Both studies relied on self-report of symptoms of depression 
while the study by Ohayon diagnosed depression and psychotic symptoms by interview 
(Ohayon 2003). No community-based study was identified that had assessed the relationship 
between OSA and symptoms of other psychiatric disorders. Community-based studies 
assessing depression both by interview and with self-report were therefore also warranted. 
Anxiety disorders as a whole are the largest diagnostic group in the general European 
population (Wittchen and Jacobi 2005). The diagnostic criteria of anxiety disorders are 
displayed in appendix 2. The second largest group of psychiatric disorders in the European 
general population is somatoform disorders with estimated prevalences of 1.1-11% (Wittchen 
and Jacobi 2005). DSM-IV descriptions of hypochondriasis, somatoform pain disorder and 
somatization disorder are displayed in appendix 3. The point prevalence of any psychiatric 
disorder defined by the DSM-III-R criteria has been estimated to be 32.8% in Norway 
(Kringlen et al. 2001) and 27% in the general, adult EU population 18-65 years of age. 
Despite the report of high prevalences of anxiety and somatoform disorders in the population 
and clinical observation of such symptoms in a high proportion of OSA patients, no previous 
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study have assessed the prevalence of these disorders among OSA patients or persons at risk 
of OSA. 
In addition to the potential effect of sleepiness as a shared risk factor between OSA 
and psychiatric disorders, age and sex are putative confounders of all associations observed in 
a clinical context (Rothman 2002). Thus, studies of associations between OSA, cognitive 
function and psychiatric disorders should ideally be designed to control for age, sex and a 
selection of previously identified, putative confounders.   
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2.0.0 Aims of the study 
 
Paper I: 
x To evaluate screening properties of the BQ in a Norwegian, general population 
based sample 
x To estimate overall, age and gender specific prevalences of OSA in a 
Norwegian general population based sample using polysomnography with 
cutoff values of 5 and 15 on the AHI as reference standards. 
Paper II: 
x To characterize cognitive function in a community-based high risk population 
for OSA 
x To investigate associations between verbal memory, executive function and 
OSA severity as assessed by the AHI, indicators of oxygen saturation and the 
arousal index before and after adjustment for putative confounders such as age, 
gender, co-morbid conditions (alcohol abuse, asthma), use of hypnosedatives, 
sleepiness, smoking and educational level. 
Paper III:  
x To estimate the prevalence of current psychiatric disorders in community-
dwelling adults at a high risk for OSA, as identified by the BQ.  
x To explore associations between OSA and current psychiatric disorders 
unadjusted and adjusted for putative confounders (demographic factors (age, 
sex, higher education and co-habitation) or established predictors for OSA 
included in the BQ).   
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3.0.0 Material and methods  
3.1.0 Design  
This thesis is based on data from the Akershus Sleep Apnea Project (ASAP), a cross-
sectional, two-phased epidemiological- clinical study, initiated by professor Kari J. Kværner, 
department of Ear- Nose and Throat, Akershus University Hospital. The cross-sectional 
design was applied in all three papers.  
3.2.0 Material 
3.2.1 Screening sample 
A questionnaire and a letter describing the study were mailed twice to a sample of 30,000 age- 
and sex-stratified inhabitants of the eastern part of Akershus (except Asker and Bærum), 
western part of Hedmark (except communities north of Trysil, Åmot and Ringsaker) and 
southern part of Oppland counties (except Vestre Slidre, Gausdal and Øyer) in central eastern 
Norway. The sample consisted of fourteen strata with 2000 randomly drawn persons from the 
National Population Register. Each stratum was classified by sex and age. Drawn males and 
females were 30, 35, 40, 45, 50, 55 or 60 years of age. In addition, two strata consisting of 
1000 males and 1000 females aged 65 years were randomly drawn.  
Questionnaires were answered by returning the paper version or via a web-based 
solution. Because 742 letters were returned unopened or we got information that the drawn 
person was deceased or abroad, the study population consisted of 29,258 subjects. Of these, 
16,302 persons responded (55.7%). Inclusion of participants to the ASAP is presented in 
Figure 2.
 Figure 2:  Inclusion of participants 
1085 BQ high-risk 687 BQ low-risk
Survey (Berlin Questionnaire), n = 30 000
Not contacted, n = 422
157 BQ low-risk378 BQ high-risk
Not answering, n = 202
Decline participation, n = 585
Excluded, n = 28
Screening sample, n = 16 302
BQ high-risk n = 3960 (24.3%)
Not available, n = 742
Not responding, n = 12 956
ASAP sample, n = 535
Random draw
233
101
353
20
189
101
232
8
Screening
phase
Clinical
phase
 
BQ = Berlin Questionnaire, ASAP = Akershus Sleep Apnea Project 
 
The response rate to the screening sample was significantly higher for persons aged 50 
years and more (62.0%) than for persons below 50 years of age (50.1%) and was higher for 
females (59.0%) than males (52.4%). Stratified response rates are presented in appendix 4. 
Males aged 30 used the web-solution most (22.3%) and females aged 65 least (1.4%). Age 
and gender stratified analyses of differences between web and paper responses revealed no 
systematic differences.  
Risk classification for OSA in the ASAP was based on a Norwegian translation of the 
BQ (Netzer et al. 1999). The English version of the BQ was translated into Norwegian using a 
standardized translation procedure. The English version was first translated to Norwegian by 
two native speaking Norwegian physicians who were fluent in English (Kari J. Kværner and 
Hilde Bergum Furuseth) and then translated back to English by two bilingual physicians 
(Torbjørn Omland and Gunnhild Karevold).  
The scoring algorithm for the BQ defines high risk for OSA as any combination of 
risk categories of daytime somnolence, snoring and hypertension or obesity (Chung et al. 
2008) (appendix 5). Thus, community-dwelling adults with high risk of OSA in this thesis all 
have combinations of two or three symptom categories as described in the scoring algorithm. 
It is also worth noting that some studies where the BQ has been administered also contain an 
additional question regarding frequency of falling asleep while driving (Hiestand et al. 
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2006;Kapsimalis and Kryger 2009). However, scoring of this additional question is not 
described in the scoring algorithm (appendix 5). Accordingly this question was not included 
in the screening questionnaire. Moreover, neither the reference article (Netzer et al. 1999) nor 
the scoring algorithm contains instructions for the handling of missing data. Missing of one or 
more BQ item occurred in 43.8% of the questionnaires in the screening sample. After careful 
consideration, missing was recoded to “zero” to establish risk status of all respondents. The 
BQ low risk questionnaires with missing items (n = 5541) were made unavailable for the 
subsequent draws.   
Also questionnaires received more than 4 months after the first mailing (n= 41) or 
without a contact telephone number (n = 729), and 672 questionnaires that were 
administratively misplaced were regarded as not eligible (n = 1442). In paper I, the screening 
sample minus these 1442 persons is labeled “the estimation sample”. 
3.2.2 Clinical sample paper I 
Five stratified, random draws were conducted (April 06, August 06, February 07, August 07 
and October 07). All draws were conducted by the project statistician, Jūratė Šaltytė Benth, in 
close co-operation with the project database manager, Anita Fjellum, who monitored 
inclusion to the clinical sample. In total, a pool of 1772 responders was randomly drawn. 
Among these, 1085 were BQ high risk persons sub-stratified by 242 persons oversampled 
with previous ear surgery, 155 persons with diabetes and 581 persons with no previous ear 
surgery, myocardial infarction or diabetes. Among these BQ high risk persons, also 107 
responders with previous myocardial infarction were randomly drawn.  
Drawn persons were invited by mail and approached by telephone. Invited persons 
were excluded after three unsuccessful attempts of contact (n = 202), use of continuous 
positive airway pressure (n = 10), pregnancy (n = 9), lack of Norwegian language skills (n = 
5), or severe physical impairment (n = 4). Because of administrative failure, 6 of these 
persons fulfilling exclusion criteria were examined but later excluded from the clinical 
sample. A total of 585 persons declined the invitation and 422 drawn persons were never 
invited, leaving a total clinical sample of 535 persons included in the overall project (378 BQ 
high risk persons, participation rate = 44.3%) (Figure 3). In paper I, 17 persons were excluded 
from analysis according to poor sleep quality (Young et al. 1993). The sample in paper I thus 
comprised of 518 persons. 
 
  
 Figure 3: The clinical samples in paper I-III: 
 
ASAP = Akershus Sleep Apnea Project, BQ = Berlin Questionnaire 
3.2.3 Clinical sample paper II and III 
Figure 3 also illustrates inclusion to the psychosomatic sub-study which is based on clinical 
examinations of the 290 first, BQ high risk participants of the ASAP between June 2006 and March 
2007. In paper III, also auxiliary analyses from ASAP controls were provided. All participants in the 
psychosomatic sub-study underwent comprehensive psychiatric and neuropsychological testing in 
addition to diagnostic procedures applied to all persons included in the ASAP.  
 The choice to assess 290 BQ high risk participants in the psychosomatic sub-study 
was based on an expected OSA prevalence of 50% among BQ high risk participants (Netzer 
et al. 1999). The prevalence of MDD among BQ high risk participants without OSA was 
expected to be approximately similar to a general population prevalence of 7% (Kringlen et 
al. 2001). Because previous community-based studies of the association between OSA and 
MDD had reported conflicting results, we aimed to detect as small differences between the 
groups as possible. We thus decided to be able to detect a 50% higher proportion of MDD 
among participants with OSA (11%) compared to participants without OSA (7%). This 
difference corresponds to an effect size of 0.15. Thus, with this effect-size, 5% alpha, 80% 
statistical power and a one-sided test, a suggested sample size is 292 
(http://www.stat.ubc.ca/~rollin/stats/ssize/b1.html). 
An overview of the screening sample, the drawn sample, the ASAP sample and the 
clinical samples are reported in Table 3.  
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Table 3: Description of the samples 
Screening factor Screening 
sample 
Drawn 
sample 
ASAP 
sample 
Clinical 
sample paper I 
Clinical sample 
paper II-III  
N  16.302  1772  535  518  290 
Mean age (SD)  47.8 (10.7)      
    High risk  48.8 (10.3) 49.1 (11.6) 48.9 (11.2) 48.6 (11.1) 48.2 (11.2) 
    Low risk  47.5 (10.8) 47.2 (11.8) 47.6 (11.4) 47.6 (11.4)  
Male sex (%)  7629 (46.8)      
    High risk  2198 (55.5) 590 (54.4) 213 (56.3) 207 (56.7) 162 (55.9) 
    Low risk  5431 (44.0) 321 (46.7) 79 (50.3) 77 (50.3)  
BQ risk categories and related variables     
I: Snoring (%)  6665(40.9)     
    High risk  3654 (92.3) 996 (91.8) 343 (90.7) 332 (91.0) 264 (91.0) 
    Low risk  3011 (24.4) 246 (35.8)** 61 (38.9)** 61 (39.9)**  
II: Somnolence (%)  4072 (25.0)     
    High risk  2498 (63.1) 682 (62.9) 261 (69.0)* 255 (69.9)* 205 (70.7)* 
    Low risk  1574 (12.8) 76 (11.1) 19 (12.1) 18 (11.8)  
III: HT or obesity (%)  3998 (24.5)     
    High risk  2624 (66.3) 745 (68.7) 252 (66.7) 240 (65.8) 193 (66.6) 
    Low risk  1374 (11.1) 71 (10.3) 15 (9.6) 15 (9.8)  
Mean BMI (SD)  26.0 (4.3)     
    High risk  29.1 (5.2) 28.4 (5.3)* 29 (5.0) 29.0 (5.0) 29.0 (4.9) 
    Low risk  25.0 (3.4) 25.4 (3.4)** 25.4 (2.9) 25.4 (2.9)  
Epworth sleepiness 
scale  
6.9 (4.0)     
    High risk  8.8 (4.5) 8.9 (4.5) 9.7 (4.5)** 9.8 (4.5)** 9.8 (4.5)** 
    Low risk  6.3 (3.7) 6.3 (3.6) 6.5 (3.9) 6.6 (3.9)  
Daily depressive 
thoughts  
1068 (6.7)     
    High risk  593 (15.3) 170 (15.9) 47 (12.6) 44 (12.3) 37 (12.9) 
    Low risk  475 (4.0) 23 (3.4) 7 (4.5) 7 (4.6)  
Stratification variables      
Diabetes (%)  546 (3.4)     
    High risk  274 (7.1) 155 (14.6)** 45 (12.1)** 44 (12.3)** 33 (11.6)** 
    Low risk  272 (2.2) 15 (2.2) 2 (1.3) 2 (1.4)  
Previous MI (%)  344 (2.1)     
    High risk  150 (3.9) 136 (12.9)** 49 (13.3)** 46 (12.9)** 41 (14.5)** 
    Low risk  194 (1.6) 11 (1.6) 2 (1.3) 2 (1.3)  
Otitis media surgery 
(%)  
2145 (28.5)     
    High risk  634 (31.5) 283 (46.7)** 110 (51.9)** 106 (52.0)** 85 (50.6)** 
    Low risk  1511 (27.4) 73 (24.4) 12 (18.2) 12 (18.8)  
a = p < 0.05, ** p < 0.01 for differences between screening sample and each of the other 
samples 
 3.3.0 Methods:  
All variables used in analyses in this thesis are presented in table 4.  
 
Table 4: Description of variables 
Strata and screening questionnaire Description  Rangea Paper 
Gender Strata variable  M/F All 
Age Strata variable 30-65 All 
Berlin Questionnaire high risk Strata variable Yes/no  All 
   Berlin Questionnaire risk category I Snoring risk category Yes/no All 
     Simple snoring Snoring any night Yes/no I 
     Habitual snoring Snoring every night or 
almost every night 
Yes/no I 
   Berlin Questionnaire risk category II Daytime somnolence Yes/no All 
   Berlin Questionnaire risk category III Body mass index >30 
and/or hypertension 
Yes/no All 
     Body mass index Calculated from 
reported height/weight 
18-51 All 
     Obesity Body mass index > 30 Yes/no All 
     Hypertension   Yes/no All 
Self-reported previous myocardial infarction Strata variable Yes/no All 
Self-reported history of ear surgery Strata variable Yes/no All 
Self-reported diabetes Strata variable Yes/no All 
Epworth Sleepiness Scale (ESS) Sum score 0-22 All 
   Excessive daytime sleepiness ESS > 10 Yes/no  All 
Frequent depressive thoughts or loss of interest 3-4 times per week or 
more 
 Yes/no III 
Self-reported asthma  Yes/no II 
Polysomnography     
Total sleep time Minutes 68-639 I, III 
SWS in percentage of Total sleep time Percentage 0-62 I 
Sleep latency to stage 1 sleep Minutes 1-479 III 
Wake time after sleep onset Minutes 0-326 III 
Sleep efficiency Percentage 16-100 III 
 
Table continued on next page 
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Table 4, continued 
 
Apnea-hypopnea index Number of apneas and 
hypopneas pr hour 
0-110 All 
Mean O2 saturation Average saturation 
during sleep 
 82-98 II 
Arousal index Arousals per hour 2-808 II 
Nadir oxygen saturation Lowest value 54-95 II 
Percentage time below 90% saturation Percentage 0-94 II 
Neurocognitive assessment   
Stroop interference time Seconds 9-85 II 
Rey Auditory Verbal Learning test score Words learned 18-61 II 
Structured Clinical Psychiatric Interview and self-report of 
depression 
   
Various DSM-IV psychiatric disordersb  SCID Diagnosed disorder Yes/no III 
Beck depression inventory Sum score 0-41 III 
Relevant standard blood tests    
Blood hemoglobin Gram/deciliter 10-18 II 
Serum ferritin Microgram/liter 5-593 II 
Demographic      
Education College/university or 
higher 
Yes/no II, III 
Co-habitation  Yes/no I, III 
In regular work  Yes/no I 
Smoking  Yes/no I 
Alcohol abuse Diagnosed disorder Yes/no II, III 
 
a = Observed range in the clinical sample 
b = See table 2-4 for specific description 
The table contains references to the articles in which the variables are described. 
Additional information of the variables not provided in the papers is described in the 
subsequent sections.  
3.3.1 The screening questionnaire 
In addition to the BQ (Netzer et al. 1999), the one page screening questionnaire (appendix 6) 
consisted of self-report of height and weight, the Epworth Sleepiness Scale (ESS) (Johns 
1991) and 31 questions specifically requested by the supervisors of the respective sub studies 
of the ASAP.  
Relevant for this thesis, one BQ item assessing snoring frequency was re-coded in 
paper I in accordance with a previous study (Partinen and Gislason 1995) with the purpose of 
comparing prevalences of snoring and habitual snoring with previous literature. Moreover, 
 body mass index (BMI) was calculated (weight (kg)/height (m)2) based on self-reported 
height and weight in all three papers. Finally, the BQ obesity/hypertension risk category was 
sub-divided into a hypertension and an obesity sub-group with the purposes of comparing 
prevalences with previous literature and clinical measurements. Agreement (Cohen’s Kappa) 
between self-reported BQ risk factors of obesity and hypertension in the screening 
questionnaire, standardized physical examination (described below) and interview of 
participants in the ASAP sample were compared. Cohen’s Kappa scores were 0.8 for obesity 
and 0.7 for hypertension respectively. Mean self-reported BMI was 28.0. Measured BMI was 
28.9 which was significantly different from self-reported BMI by paired samples t-test. 
The ESS (Johns 1991) is a frequently used questionnaire assessing subjective 
sleepiness. The Norwegian translation used in this thesis has previously been used to estimate 
prevalence and risk factors of EDS in Norway (Pallesen et al. 2007). Internal consistency of 
the ESS as assessed by Cronbach’s alpha in both the screening sample and in the clinical 
sample was 0.8. The test-retest reliability between the screening sample and the clinical 
sample was 0.7 as assessed by the Intraclass Correlation Coefficient.  
Finally, in paper III, information regarding daily depressive thoughts was used in 
analyses assessing selection bias between the screening- and clinical samples.  
3.3.2 Polysomnography (PSG) 
The technical specifications of the in-hospital polysomnographic equipment used in the ASAP 
and clinical scoring procedures have been comprehensively described in Paper I. In addition 
to measures of respiratory events, oxygen saturation and arousals, various variables of sleep 
quality have been reported in the three papers (total sleep time, slow wave sleep in percentage 
of total sleep time, sleep latency, wake time after sleep onset and sleep efficiency).  
Regarding the oximetry variables, inspection of summary graphs of the initially scored 
sleep reports revealed potential artifacts in the oximetry variables from 68 participants of the 
psychosomatic subsample. The scoring of oximetry variables from these participants were re-
inspected by the original two scorers (Janne Grønli and Ingvild West Saxvig) and artifacts 
were corrected in oximetry data for 40 participants where obvious artifacts were identified.  
3.3.3 Cognitive tests  
Among cognitive domains previously shown to be affected in OSA, it was decided to assess 
verbal (declarative) memory by the Rey Auditory Verbal Test (RAVLT) (Schmidt 1996) and 
executive function by a shortened version of the Comali/Kaplan Stroop test (Egeland et al. 
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2003). The shortened version of the Comali/Kaplan Stroop test (Egeland et al. 2003) was used 
to assess response inhibition which is regarded a measure of executive function. Compared 
with other tests of executive function, the Stroop test adjusts for attention, which should 
optimally be controlled for when assessing executive function (Verstraeten and Cluydts 
2004). General population norms have not been published for this version, and norms were 
calculated from an available data set (Rund et al. 2006).  
Normative data from a meta analysis of the RAVLT was used for comparison 
regarding this test (Mitrushina et al. 2005).   
 The two neurocognitive tests were chosen because they were short regarded 
extensively validated and they were available with norms without costs through our co-
operation with Professor Kjetil Sundet. Finally, both tests were listed by Decary et al. in a 
proposed test battery of cognitive functions related to OSA (Decary et al. 2000). 
3.3.4 Psychiatric assessments 
Diagnostic interview 
Current (criteria met within the past month) psychiatric disorders were diagnosed by the 
structured clinical interview for DSM-IV, axis I-disorders (SCID-I) (First Michael B et al. 
1995). The SCID-I is regarded the gold standard research tool for assessment of psychiatric 
disorders. Interviews were conducted by me and taped. I was trained by an experienced 
research psychiatrist (TD) for 9 months before the initiation of the study.  
Inter-rater reliability of the interview was assessed in two ways: The first 30 
interviews in the study plus another 44 cases with unclear diagnoses were analyzed separately 
by HHS and TD and discussed until consensus was reached. Secondly, Cohen’s Kappa values 
for agreement between diagnoses obtained by TD and me in 40 randomly selected interviews 
were calculated for the following categories: MDD, somatoform pain disorder and a 
composite category termed “current anxiety”. The latter category included participants who 
suffered from at least one current anxiety disorder (panic disorder with and without 
agoraphobia, social phobia, obsessive-compulsive disorder, post-traumatic stress disorder and 
generalized anxiety disorder). Specific phobia was not included because the disorder was 
regarded as clinically less important. A composite category for anxiety was composed 
because of few cases with each anxiety disorder. The inter rater reliability scores for 
presence/absence of the selected three diagnostic categories (MDD, somatoform pain disorder 
and current anxiety) were excellent (Cohen’s kappa = 1.0) (Landis and Koch 1977). 
 Self-report of depressive symptoms  
Current symptoms of depression were assessed by the Beck Depression Inventory, version I 
(BDI) (Beck et al. 1961). The BDI consists of 21 items of affective, cognitive and somatic 
symptoms of depression, each scored 0-3 (Beck et al. 1961)(appendix 7). The BDI has been 
frequently used to assess severity of depression and was regarded best for comparisons with 
other studies of depression related to OSA. The internal consistency for the BDI in the ASAP 
sample, as assessed with Cronbach’s alpha was 0.9, which is regarded excellent. 
3.3.5 Fasting blood samples 
Morning fasting blood samples were collected from the antecubital vein of all participants. 
Standard tests including blood hemoglobin and ferritin used in paper III were analyzed the 
same day by conventional enzyme-assays at the laboratory at Stensby Hospital.   
3.3.6 Demographic variables: 
Demographic data in addition to age and gender was based on information from a validated 
standardized questionnaire from the Cohort of Norway (Naess et al. 2008). Specific variables 
derived from these variables are described in the respective papers. 
3.3.7 Clinical interview and examination: 
All participants underwent a semi-structured interview where previous illness and medication 
use was registered. In addition, a standard clinical examination was performed, including two 
repeated measures of weight and height. BMI was calculated by the formula described above.  
 
3.5.0 Ethics 
The study protocol was approved in 2005 by the Regional Committee for Medical Research 
Ethics in eastern Norway, the National Data Inspectorate, The Norwegian Directorate of 
Health and the Norwegian Social Science Data Services. All participants received written 
information by mail. A written consent for participation was obtained before inclusion to the 
ASAP sample. If the examinations performed revealed signs of any disease needing attention, 
the person’s general practitioners was informed if the participant consented.  
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3.6.0 Statistical analyses 
3.6.1 Quality control:  
Data from the screening questionnaire was manually scanned and corrected consecutively. Data from 
PSG reports of the clinical sample in paper II-III, neurocognitive tests and the psychiatric interview 
was punched manually by me into a research database. Remaining PSG data, data from standard 
blood samples, clinical interview and examination and self-report data from participants that were 
not able to answer the computerized questionnaires were punched into the database by other 
researchers or by a technician.  
The quality of all data was thoroughly checked prior to scientific analyses by descriptive 
statistics assessing range and outliers. Values out of range and extreme outliers were checked against 
raw data and eventually corrected in the database. All corrections were logged.   
3.6.2 Estimation of BQ properties and prevalences of OSA 
The quality control procedures revealed that a systematical bias had occurred when including 
BQ low risk participants to the clinical sample. A decision to exclude BQ low risk 
respondents from the random draws was the mechanism of this systematical bias. 
Respondents that had answered “no” to the question “do you snore” were more likely to not 
fill in other questions regarding snoring loudness and frequency than snorers. It was decided 
to adjust for this bias in the same statistical model that adjusted for stratified sampling in 
paper I. A description of this statistical procedure is published as an online supplement to 
paper I (appendix 8).  
3.6.3 General statistical considerations 
All continuous data were tested for normality by the Kolmogorov-Smirnov test. Non-
normalized variables were either log-transformed and re-checked for normality, or 
categorized. Comparisons between participants and non-participants were performed with Chi 
Square test for categorical variables and Student’s T-test /Mann Whitney U-test for normally 
distributed/ non-normally distributed continuous variables respectively. Bivariate correlations 
were assessed with Pearson’s correlation coefficient or Spearman’s rho, as appropriate. More 
detailed descriptions of statistical considerations and multivariate analyses are presented in 
each paper.  
  In all analyses a two-tailed p-value < 0.05 was used as cut-off for statistical 
significance. All statistical analyses were obtained by using the Statistical Package for Social 
Sciences, versions 16.0-18.0. 
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4.0.0 Summary of papers and results 
 
4.1 Paper I 
A Norwegian Population-based Study on the Risk and Prevalence of Obstructive Sleep 
Apnea  
 
Summary 
The BQ is a widely used screening tool for OSA, but its performance in a general population 
based sample is unknown. The prevalence of OSA in middle-aged adults is not known in 
Norway. Accordingly, the aims of the current study were to evaluate the utility of the BQ for 
OSA screening in the general population and to estimate the prevalence of OSA in Norway. 
The study population consisted of 29,258 subjects (aged 30–65 years, 50% female) who 
received the BQ by mail. Of these, 16.302 (55.7%) responded. 518 persons were included in 
the clinical sample and underwent in-hospital polysomnography. Screening properties and 
prevalence were estimated by a statistical model that adjusted for bias in the sampling 
procedure. Among the 16.302 respondents, 24.3% (95% CI = 23.6–25.0%) were classified by 
the BQ to be at high risk of having OSA. Defining OSA as an AHI t 5, the positive predictive 
value of the BQ was estimated to be 61.3%, the negative predictive value 66.2%, the 
sensitivity 37.2% and the specificity 84.0%. Estimated prevalences of OSA were 16% for 
AHI ≥ 5 and 8% for AHI ≥ 15. In conclusion, the BQ classified one out of four middle-aged 
Norwegians to be at high risk of having OSA, but the screening properties of the BQ were sub 
optimal. The estimated prevalence of OSA was comparable to previous estimates from 
general populations in the US, Australia and Europe.  
 
  
 4.2 Paper II 
Average nightly oxygen saturation, verbal memory and executive function in 
population-dwelling adults at high risk of having obstructive sleep apnea 
 
Summary 
Purpose: Cognitive functions in community-dwelling adults at high risk of OSA have not 
been described, nor are associations between cognitive functions and OSA severity fully 
understood. The study aimed to describe verbal memory and executive function in 
community-dwelling adults identified by the BQ and to investigate associations between these 
cognitive domains and different OSA severity indicators. 
Methods: Among 29,258 age- and gender stratified persons 30–65 years who received the 
BQ by mail, 16,302 (55.7%) responded. From 654 randomly drawn respondents with BQ high 
risk who were approached for study participation, 290 participants (55.9% males, mean age 
48.2 years) were included. Verbal memory was assessed by RAVLT and executive function 
by the Stroop test. OSA severity indicators were assessed by polysomnography. 
Results: Mean (standard deviation) verbal learning score was 
42.0 (8.9), mean interference time was 31.1 (12.7), median (25th percentile, 75th percentile) 
AHI was 7.7 (2.4–22.2) and mean average oxygen saturation was 94.3 (2.0). Verbal learning 
score was independently associated with average oxygen saturation (β = 0.721, p = 0.025) in 
multivariate linear regression models adjusted for putative confounders. Interference time was 
only related to OSA severity indicators in bivariate analyses. 
Conclusions: Verbal memory and executive function impairments were mild in community-
dwelling adults at high risk of OSA. Average oxygen saturation was the indicator of OSA 
severity most strongly associated with cognitive function. 
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4.3 Paper III 
Sleep apnoea, anxiety, depression and somatoform pain: A community-based high risk 
sample 
 
Summary 
OSA has been associated with psychopathology. However, community-based studies that 
measure both psychiatric diagnoses and OSA are lacking. This study reports current 
psychiatric disorders in community-dwelling adults at high risk for OSA identified by the BQ. 
Further, associations between OSA and current psychiatric disorders, unadjusted and adjusted 
for putative confounders, are reported.  
A sub sample of the ASAP consisting of 290 adults, 30–65 years, with positive BQ 
screening, underwent the SCID-I and polysomnography. Auxiliary analyses from ASAP 
controls are provided.  
The median AHI score in the sample was 7.7 (25th percentile 2.4, 75th percentile 22.2). 
Major depressive disorder, current anxiety and somatoform pain disorder were diagnosed in 
12.4%, 14.8% and 19.3% of participants, respectively. At least one psychiatric disorder was 
diagnosed in 110 (37.9%) participants. The odds ratio of participants with OSA for having a 
psychiatric disorder compared with participants without was 0.54 (95% CI = 0.33–0.88). A 
negative association did not persist in the auxiliary sample. Results with OSA defined by AHI 
≥15 and AHI ≥30 is presented in appendix 9.  
In conclusion, more than one-third of participants in a community-based, BQ high-risk 
sample were diagnosed with a psychiatric disorder. A negative association between OSA and 
psychiatric morbidity was found.  
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5.0.0 General discussion  
5.1.0 Methodological issues  
5.1.1 Design 
The strength of the community-based two-phase design is that results may be generalized to 
the general population if properly weighted. Only the results in paper I were weighted. Hence, 
the results in paper II and III may be generalized to community-dwelling persons with BQ 
high risk. However, in paper III, also results from a BQ low risk population were provided. 
Finally, it must be kept in mind that the cross-sectional design of the study limits 
interpretation of causal relations. 
5.1.2 Sample 
Sample size 
The size of the screening sample and the ASAP sample and the decision that 3/4 of the 
participants should fulfill criteria of BQ high risk status were set prior to the planning of the 
thesis. However, the size of the clinical sample in paper I was large enough to build a 
prediction model that yielded estimates of screening properties and prevalences with 
relatively narrow 95% confidence intervals.  
Regarding the sample size calculation leading to the decision to assess cognitive 
function and psychiatric disorders only among BQ high risk participants, the empirical 
observation of significantly more psychiatric disorders among participants without OSA than 
with OSA were different from the assumption behind these estimates. On the other hand, the 
size of the clinical sample in paper II and III was sufficiently large to reject the null 
hypothesis of no differences in psychiatric disorders as a whole between participants with and 
without OSA. The effect-size of this difference was 0.31. It is, however, possible that in a 
larger sample, differences on the level of individual psychiatric disorders could have been 
found. The effect-size of the non-significant difference between MDD and OSA was 0.26. 
Thus, if the sample-size had been calculated with a two-sided test, rather than a one-sided test, 
significant differences between individual psychiatric disorders and OSA might have been 
found in a larger sample.   
 Internal validity 
The discussion of internal validity has been categorized between investigator-dependent 
factors and participant-dependent factors.  
Investigator-dependent factors 
The most important investigator-dependent factor affecting the results of paper I was the 
handling of missing items in the BQ. No recommendations in the existing literature regarding 
the BQ on how to deal with this problem were found. Accordingly, a sensitivity analysis was 
performed to estimate the maximum impact of the potential bias introduced by our strategy of 
scoring missing values as zero was conducted. The analysis indicated that “most severe 
scoring on missing items” would increase the proportion of BQ high risk participants in the 
screening sample from 24.3% to 27.7%. Thus, the analysis suggested a minor effect on BQ 
high risk classification. However, as reported in section 3.6.2, quality control procedures 
revealed that contrary to the decision of scoring missing values as “zero”, all BQ low risk 
questionnaires with missing items (n = 5541) had been made unavailable for the subsequent 
draws, apparently to avoid misclassification among persons recruited to the clinical part of the 
project. This decision, unknown for me before analyzing data, resulted in a selection of 
snorers to the BQ low risk group in the ASAP sample and the clinical samples. The effect of 
the bias can be seen among BQ low risk participants in the BQ snoring category of table 3. 
The most plausible mechanism of this bias is that responders who had indicated “no snoring” 
on the first question of the BQ snoring category were more likely to have missing values in 
further items than responders that reported snoring. Because snoring is an established risk 
factor of OSA, this bias probably contributed to a higher proportion of OSA among BQ low 
risk participants than intended. Thus, this bias would have contributed to lower estimated 
diagnostic properties of the BQ and higher prevalence estimates of OSA if not corrected. 
Therefore, estimated screening properties of the BQ and estimated prevalences of OSA were 
calculated by a multivariate logistic regression model that was evaluated by advanced data 
simulation (appendix 8). This model also accounted for the multi-stage sampling procedure 
and sub-stratifications in the BQ high risk group.  
A limitation to the model was that is was based on the estimation sample (Paper I, 
table 1) rather than the whole screening sample. However, in the discussion of paper I we 
argue that this sample was representative of the screening sample because of the lack of 
differences between these samples.  
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A final limitation to the statistical model is that the use of the model is founded on the 
assumption that associations between self-report items used in the statistical model and OSA 
pathology are constant through the severity specter of the AHI. This assumption can of course 
be questioned, but we argue in paper I that the internal and external validation procedures of 
the model secure that the results provided by the model can be generalized to the general 
population.  
Among factors that was not controlled for in the statistical model, the use of exclusion 
criteria during telephone approach of randomly drawn persons might have influenced the 
results. Physiological changes in pregnancy were expected to affect both reported daytime 
sleepiness and biomarkers assessed in other sub-studies of the ASAP. Moreover, limitations 
of the sleep laboratory prevented persons with physical disabilities to attend. Exclusion by 
pregnancy and physical disabilities probably affected estimated properties of the BQ and the 
prevalence estimates to a minor degree. However, exclusion of persons with prior CPAP 
treatment to the clinical samples probably contributed to an underestimation of screening 
properties of the BQ and prevalence of OSA because persons with presumably moderate to 
severe OSA were excluded. Moreover, the PSG equipment was incompatible with the use of 
CPAP masks, and sleep registration without treatment was considered both unethical and 
scientifically wrong because sleep registration without such masks would affect the relations 
to psychiatric disorders and cognitive function measured prior to sleeping. The 
underestimation potentially caused by excluding persons with CPAP treatment was also 
counterbalanced by a participant dependent selection mechanism: Analyses of participation 
bias indicated that persons previously treated for sleep disorders were more likely to 
participate than untreated persons. The proportion of participants in the ASAP sample with 
previous treatment of sleep disorders was 10.2%, which was significantly higher than the 
proportion among non-participants (6.3%). Moreover, 12.2% of participants with OSA (AHI 
≥ 5) in the ASAP sample had previously received treatment for sleep disorders, which was 
significantly higher than 6.9% among participants without OSA. Thus, this bias probably 
contributed to an overestimation of BQ screening properties and the prevalence of OSA with 
opposite effect than the effect of the bias caused by excluding CPAP-users. 
Exclusion (paper I) of participants with total sleep time <240 minutes or no rapid eye 
movement sleep was also not adjusted for in the statistical model. This exclusion criteria was 
adapted from the Wisconsin Sleep Study (Young et al. 1993). The decision to exclude these 
participants was made in order to strengthen reliability of the reference standard 
polysomnography when calculating prevalence estimates and screening properties of the 
 Berlin Questionnaire. When compared to the clinical sample in paper I, these 17 persons did 
not differ significantly regarding AHI or sex. However, the 17 persons were significantly 
older (55.3 years) than persons included in the clinical sample of paper I (48.3 years, p = 
0.012). Accordingly, despite the benefit of improving the reference standard by excluding 
these persons, the decision might have reduced the effect of older age in the model. On the 
other hand, the mean age of participants of the clinical sample in paper I was higher than the 
mean age in the screening sample. Thus, the bias probably has little impact on external 
validity. In paper II and III, persons with poor sleep quality were not excluded from analyses.  
Regarding the clinical sample in paper II and III the consecutive inclusion of 290 BQ 
high risk participant out of a total of 378 eligible participants in the ASAP sample potentially 
influenced the internal validity. When comparisons were made between this sample and the 
remaining 88 BQ high risk participants not included in the sample, no differences in the 
variables examined were found except for age. The mean age of participants in the clinical 
sample in paper II and III was 48.2 years while among non-participants it was 51.1 years (p= 
0.033). Thus, because age was found to be a strong predictor of cognitive function, this 
selection might have increased cognitive test scores in paper II. On the other hand,  because 
the participants of the psychosomatic sample did not differ significantly from the 88 BQ high 
risk non-participants regarding BDI sum score or ESS sum score, and because age was not 
significantly related to the risk of having psychiatric disorders, the impact of this selection on 
the results in paper III is probably minor.   
Participant-dependent factors 
The main participant dependent bias in addition to the selection of persons previously treated 
for OSA as described above was the selection of persons with daytime somnolence or daytime 
sleepiness in the BQ high risk group as indicated in Table 3. Persons with BQ high risk 
experiencing daytime sleepiness were more likely to participate in the study than persons 
without daytime sleepiness. However, the proportion of persons reporting frequent depressive 
thoughts was not different between participants and non-participants (Table 3). In order to 
gain further knowledge of the effect of this participation bias on BQ high risk status, the 
following post-hoc analysis was performed: Table 5 present possible combinations of BQ 
high risk in the screening sample and Table 6 presents the same data in the clinical sample 
from paper I.  
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Table 5: Percentage distribution between Berlin Questionnaire sub-groups in the 
screening sample in total and by age ≥ 50 years and male sex 
BQ high risk, N= 3960 Age ≥ 50 Males 
   Snoring and somnolence, N=1336 (33.7%) 26.1 % 33.5 % 
   Snoring and obesity/HT, N=1462 (36.9%) 45.5 % 41.0 % 
   Somnolence and obesity/HT, N=306 (7.7%) 7.2 % 4.4 % 
   All risk categories, N= 856 (21.6%) 21.1 % 21.1% 
BQ = Berlin Questionnaire, HT = hypertension,  
Table 6: Percentage distribution between Berlin Questionnaire sub-groups in the clinical 
sample from paper I in total and by age ≥ 50 years and male sex 
BQ high risk, N= 365 Age ≥ 50 Males 
   Snoring and somnolence, N=125 (34.2%) 24.9 % 34.3 % 
   Snoring and obesity/HT, N=110 (30.1%) 37.6 % 34.3 % 
   Somnolence and obesity/HT, N=33 (9.0%) 10.2 % 3.9 % 
   All risk categories, N= 97 (26.6%) 27.4 % 27.5% 
BQ = Berlin Questionnaire, HT = hypertension,  
 
Within the tables, stratification by age and sex seem to affect the internal distribution 
between BQ sub categories to a larger extent than selection from the screening sample to the 
clinical sample in paper I observed when comparing the tables. Selection bias by subjective 
sleep complaints thus appears to affect BQ sub categories to a minor extent when compared to 
selection by age and sex. Subsequently, these post-hoc analyses illustrates that both age and 
gender influence the internal distribution of BQ high risk which should be considered when 
interpreting the results of paper II and III. For example, the risk of having a psychiatric 
disorder was higher and the risk of having OSA was lower in females (paper III, Table 3). 
Because lesser females than males were found in combinations with snoring and somnolence 
and snoring and obesity/hypertension, the internal distribution of BQ high risk thus might 
have inflated confounding by sex in paper III. However, adjustment for sex did not 
significantly alter the associations observed between psychiatric disorders and OSA.  
External validity 
Regarding external validity of results from the screening sample, the main limitation to 
generalizing to the general population is the response rate. Although the response rate of 
55.7% in the ASAP was better than response rates of 20% and 22% respectively in the two 
US studies that previously have used the BQ in a general population setting (Hiestand et al. 
 2006;Kapsimalis and Kryger 2009), response bias might have influenced all results presented 
in this thesis. In order to assess any impact of response bias, we assessed differences in the 
response rates (appendix 4) regarding age and gender. The response rate to the screening 
sample was significantly higher for subjects aged 50 years and more (62.0%) than for persons 
less than 50 years of age (50.1%), and was higher for females (59.0%) than males (52.4%). 
Thus, all estimates in this thesis are more precise for persons aged 50 years or more compared 
to persons less than 50 years of age and for females compared to males in the general 
population.  
In addition to age- and gender, we believe the most likely factor of systematic 
selection (if any) between responders and non-responders to our questionnaire were subjective 
sleep complaints. We therefore also compared sleepiness in the screening sample with a 
representative, Norwegian study assessing sleepiness by the same questionnaire (Pallesen et 
al. 2007). The mean age in this study was 47.6 years, the mean self- reported BMI was 24.7 
and the mean ESS score was 7.0, which is almost identical to the ESS score found in the 
screening sample of our study. The similarity with this other Norwegian, general population 
sample strengthens the external validity of the screening sample.  
Finally, regarding sleepiness, it is worth noting that the prevalence of EDS in the 
Norwegian general population as defined by an ESS >10 in the study by Pallesen et al. and in 
the screening sample both was 17.7% (Pallesen et al. 2007). When compared to the original 
general population prevalence estimate of 5.9% with EDS by Johns et al. (Johns 1991), 
Norwegian adults today report more sleepiness than Australian adults reported 20 years 
earlier.  
Regarding external validity of the estimates in paper I, the use of cut-off values of the 
AHI as a diagnostic criterion for OSA is not directly comparable to a diagnosis of OSA. 
According to the ICSD-2 criteria (table 1), all BQ high risk participants with AHI >5 by 
definition fulfill the B criterion for OSA. However, some BQ low risk participants with an 
AHI >5 did not fulfill the symptom criterion for OSA. Moreover, the ICSD-2 D criterion 
states that “the disorder is not better explained by another current sleep disorder, medical or 
neurological disorder, medication use or substance use disorder”. Thus, it is important to bear 
in mind that OSA diagnosed by a simple cut-off value of the AHI is not directly comparable 
to a clinical diagnosis of OSA as defined by the ICSD-2.  
Regarding paper II and III, the external validity of the BQ high risk clinical sample in 
paper II and III is only directly comparable to persons with BQ high risk in the general 
population. However, although not directly comparable to the general population as a whole, 
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the results in paper II and III add knowledge from a community-based sample to complex 
associations between OSA and cognitive function and psychiatric disorders respectively.   
5.1.3 Assessments 
The verification of data quality by two investigators, minimizing random errors in creating the 
database increases the reliability of the results assessed. Moreover, the prospective collection 
of clinical data by established methods, performed standardized and punched into the research 
database by few investigators also increases the reliability in general.  
The screening questionnaire 
Data from each of the three BQ symptom categories might be affected by information bias. 
Self-reported snoring is in most cases dependent of a bed partner that actually acknowledge 
the symptoms to occur while the person is sleeping. Moreover, the BQ has a “don’t know” 
response alternative that affect psychometric properties (Fedson et al. 2012). However, there 
is a lack of consensus over how to analyze such responses.  
Regarding the BQ somnolence category, the time frame is diffuse. This may in 
particular affect the question regarding falling asleep while driving. Inclusion of the additional 
question used by Hiestand et al. and Kapsimalis and Kryger regarding frequency of falling 
asleep while driving could thus have altered the properties of the BQ somnolence category 
(Hiestand et al. 2006;Kapsimalis and Kryger 2009). More importantly, the construct of 
sleepiness is complex (Cluydts et al. 2002), and self-report of daytime somnolence or 
sleepiness has been shown to be influenced more strongly by symptoms of depression than 
OSA severity in another community-based sample (Bixler et al. 2005). Finally, in a study 
from 1997, Engleman et al. compared pre- and post treatment ESS scores of sleepiness prior 
to treatment and found that participants with OSA systematically underscored sleepiness prior 
to treatment (Engleman et al. 1997).  
The reliability of data in the BQ risk category based on self-reported hypertension and 
obesity is to a lesser degree affected by information bias. However, health seeking bias will 
obviously affect the reliability of these data to some extent. Unfortunately, community-based 
studies of the relationship between self-reported hypertension and measured hypertension 
could not be identified.   
Regarding the ESS, A Norwegian version with a slightly different translation 
regarding the Norwegian word for “dozing off” has recently been validated (Beiske et al. 
2009). This Norwegian version of the ESS had acceptable internal consistency and test-retest 
reliability with internal consistency reliability, as assessed with Cronbach’s alpha, of 0.8 and 
 test–retest reliability of 0.8, as assessed with the intra-class correlation coefficient. In the 
study by Beiske et al., as in other validation studies of the ESS, individual items and the ESS 
score was only fair to moderately associated with results from the multiple sleep latency test. 
Polysomnography 
A major strength of this study was that sleep was assessed by polysomnography. However, it 
was decided to rely on a clinical scoring rather than a scientific scoring algorithm. As 
illustrated in Figure 1, the spectrum of sleep disturbed breathing is broader than the spectrum 
of OSA. Thus, a more comprehensive assessment of sleep containing both respiratory related 
arousals and assessment of pCO2 would have given information regarding the whole spectrum 
of sleep disturbed breathing. It is also worth noting that scoring with other definitions of 
obstructive events, including different thresholds of desaturation regarding hypopneas, could 
have influenced the results presented in the thesis (Redline et al. 2000). Hypopneas were only 
scored by a pre-defined definition of ≥ 4% oxygen desaturation. Moreover, neither arousals 
nor pCO2 is usually registered in clinical practice. Accordingly, the focus on OSA as assessed 
by the AHI or oxygen variables in this study thus reflects everyday clinical practice.   
Moreover, the use of only one single, sleep registration is a potential limitation to the 
reliability of sleep assessment (Stepnowsky, Jr. et al. 2004). Ideally, sleep should be measured 
twice, but in accordance with most previous studies that have assessed screening properties of 
the BQ or prevalence of OSA, we chose to rely on a single measure of sleep. However the use 
of an in-hospital assessment of sleep strengthened the internal validity of the PSG assessments 
compared to studies that have relied on portable solutions. Participants thus went to sleep at 
will without potential disturbing factors in a home setting, and remained sleeping until 
naturally awake.  
The use of two scorers also was a potential limitation to the PSG data although they 
were completely blinded for BQ risk status. Inter rater reliability between these two raters was 
not assessed. However, these two raters have co-operated for almost 10 years, they were 
licensed simultaneously and they arrange courses in PSG-scoring in Norway together every 
year. It is therefore likely that they score sleep relatively similarly.  
Another approach that increased the reliability of the PSG assessments was the 
screening for artifacts in oximetry data. In particular, variables measured at one or a few time 
points during the night (lowest oxygen saturation and time below 90% saturation) are 
vulnerable to artifacts. At the contrary, variables such as the mean oxygen saturation and the 
oxygen desaturation index are measured over a longer period of time. Accordingly, the effect 
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of artifacts is attenuated in these variables. However, results in paper II and III were only 
changed to a minor degree when artifacts in oxygen variables had been removed.    
Cognitive tests 
Cognitive function was assessed by the same physician at identical time points the day prior 
to polysomnography, thus eliminating problems with inter-rater reliability. Moreover, the tests 
were chosen from a list proposed by Decary et al. (Decary et al. 2000) for use in OSA 
patients. However, the limited number of tests increased the probability of a type two 
statistical error (i.e., finding no association when the association is truly present).  
 Unfortunately, intra-rater reliability was not assessed regarding the neurocognitive 
testing. However, I was comprehensively trained by Professor Kjetil Sundet prior to 
presenting the tests to the participants of the study.  
The tests should ideally have been performed after the sleep studies. However, with 
the chronic nature of OSA, I believe the validity of the neurocognitive assessments was only 
to a minor degree affected by this limitation.  
 Finally, it is conceptually problematic to assess higher brain functions related to OSA 
without also assessing the underlying level of alertness (Verstraeten and Cluydts 2004). In the 
Stroop test, speed is adjusted for. However, regarding the RAVLT, the influence of alertness 
on the results is not known.  
Psychiatric assessments 
The SCID-I interview yields highly reliable diagnoses of DSM–IV axis I disorders and is 
often considered as the gold standard of diagnostic assessments in clinical research.  
In the present study, one physician underwent extensive training in performing the interview. 
In addition, all interviews were taped. The finding of an excellent inter-rater reliability 
strengthens the reliability of the diagnoses obtained.  
The diagnostic approach by the SCID-I in this thesis was included in the SCID 
manual. Thus, only the somatoform dimension of pain was assessed. Valuable information 
regarding other somatoform symptoms such as nausea, dizziness, bowel symptoms etc. was 
therefore not registered. 
Further, because of low prevalence on each anxiety disorder, I chose to merge all 
anxiety disorders into one category of current anxiety. This choice clearly leads to a loss of 
information regarding the complexity of anxiety disorders.     
  Regarding the BDI, the internal consistency was satisfactory, as evaluated by 
Crohnbach’s alpha. However, previous studies of the BDI in various populations have 
demonstrated excellent psychometric properties of this questionnaire.  
Demographic variables 
The assessment of demographic variables was mainly based on computerized versions of 
validated questionnaires. Most participants managed to complete these versions without help. 
However, when assistance was needed, it is possible that this assistance might have 
influenced responses to some extent. However, all physicians involved in the collection of 
data were instructed not to provide other than technical support.  
5.1.4 Summary of methodological considerations 
Acknowledging the methodological strength and weaknesses discussed above, I regard the 
samples defined and the data collected reliable and valid for answering the research questions 
of this study. However, post-hoc analyses of internal validity and analyses of external validity 
of the screening questionnaire indicated that a particular focus should be given to the effect of 
age, gender and obesity when interpreting the results of this study.  
Regarding generalizability, the results from paper I can be generalized to the general 
population while level of cognitive function and prevalences of psychiatric disorders reported 
in paper II and III should be generalized only to a community-based BQ high risk population. 
On the other hand, given the limitations discussed above, I regard the community-based 
clinical sample in paper II and III suitable for assessing associations between OSA, cognitive 
function and psychiatric disorders respectively.  
  
5.2.0 Results and Clinical Implications 
5.2.1 BQ screening properties in the general population 
The proportion of persons categorized to be at high risk for OSA in the screening sample was 
consistent with other studies that have distributed the BQ to a general population sample 
(Hiestand et al. 2006;Kapsimalis and Kryger 2009;Shepherd et al. 2011). However, the 
estimated diagnostic properties of the BQ when distributed to a general population sample 
were found to be sub-optimal. No previous studies of BQ properties when distributed to a 
general population sample could be identified. Little is also known regarding properties of 
other screening questionnaires for OSA when distributed to general population samples 
(Abrishami et al. 2010;Harding 2001;Pang and Terris 2006;Rowley et al. 2000). However, a 
Obstructive Sleep Apnea in Community-Dwelling Adults  
57 
 
poster presented in the “Sleep 2011” in Minneapolis replicated our findings regarding 
screening properties of the BQ when being administered to a Swiss general population 
(Andries 2011). Finally, the study by Gantner et al. also reported sub-optimal properties of the 
BQ when distributed to a general population sample with high cardiovascular risk (Gantner et 
al. 2010).  
A major challenge when interpreting screening properties of the BQ in a general 
population sample is how to understand sub groups of BQ high risk persons. As presented in 
Table 5 and 6, age and gender were found to be differently related to each sub group of BQ 
high risk. Moreover, Table 7 illustrates that also unadjusted screening properties varied 
between BQ high risk combinations.   
Table 7: Unadjusted diagnostic properties of the Berlin Questionnaire and Berlin 
Questionnaire risk groups. 
Total sample: N= 518 AHI ≥ 5 AHI < 5 AHI ≥ 15 AHI < 15 
BQ high risk, N= 365  227 138 130 235 
   Snoring and somnolence, N=125 (34.2%)    66    59    28    97 
   Snoring and obesity/HT, N=110 (30.1%)    78    32    51    59 
   Somnolence and obesity/HT, N=33 (9.0%)    14    19    5    28 
   All risk categories, N= 97 (26.6%)    69    28    46       51 
BQ low risk, N= 153  61 92 27 126 
Diagnostic properties:   
LR+ (CI) 1.3 (1.2, 1.5)*  1.3 (1.1, 1.4)* 
   LR+ by snoring and somnolence 1.3 (1.0, 1.7) 1.2 (0.9, 1.6) 
   LR+ by snoring and obesity/HT 2.2 (1.6, 3.0)* 2.1 (1.6, 2.7)* 
   LR+ by somnolence and obesity 1.1 (0.6, 2.0) 0.9 (0.4, 2.1) 
   LR+ by all risk categories 2.3 (1.6, 3.3)* 2.2 (1.6, 2.9)* 
LR- (CI) 0.5 (0.4, 0.7)* 0.5 (0.3, 0.7)* 
   LR- by snoring and somnolence 0.8 (0.6, 1.0) 0.9 (0.6, 1.2) 
   LR- by snoring and obesity/HT 0.6 (0.5, 0.7)* 0.5 (0.4, 0.7)* 
   LR- by somnolence and obesity/HT 1.0 (0.9, 1.1) 1.0 (0.9, 1.2) 
   LR- by all risk categories 0.6 (0.5, 0.8)* 0.5, 0.4, 0.7)* 
AHI= Apnea Hypopnea Index, BQ = Berlin Questionnaire, HT = hypertension, CI = 
Confidence Interval, LR+ = Likelihood Ratio for AHI above cut-off, LR- = Likelihood Ratio 
for AHI below cut-off , * = LR significantly different from 1 
 The table illustrates that unadjusted screening properties of the BQ as indicated by 
likelihood ratios varied to an extensive degree between BQ sub-groups. Only ratios are 
presented in order to avoid weighting for different size of the BQ high risk sub-groups. The 
unadjusted positive and negative likelihood ratios for the BQ high risk versus BQ low risk 
indicate that screening properties were better in BQ risk groups without the BQ somnolence 
category than in BQ risk groups with the BQ somnolence category. I thus believe the relation 
between BQ somnolence or sleepiness and OSA is a key factor in interpreting the results of 
paper II and III.  
The effect of different BQ screening properties regarding age and sex is best illustrated 
in Table 3 in paper III where the odds of having OSA defined as AHI ≥ 5 is reported to be 
significantly higher in males compared to females and in persons  ≥ 50 years of age compared 
to persons less than 50 years. At the same time, the odds of having psychiatric disorders 
showed the opposite pattern. Accordingly, the BQ performed worse in sub-groups with high 
risk of psychiatric disorders. In line with the findings by Bixler et al. (Bixler et al. 2005), 
sleepiness was also higher in these sub-groups of the BQ.   
In addition to the strong association between sleepiness and psychiatric disorders in 
the general population, a potential mechanism for the inverse relation between sleepiness and 
OSA reported in this thesis is the underreporting of sleepiness in OSA as discussed above 
(Engleman et al. 1997) and the differences between objective and subjective sleepiness per se 
(Cluydts et al. 2002).  
The estimated BQ properties were also highly dependent on the definition of OSA 
applied. If we had chosen to define OSA by the AHI and daytime somnolence, screening 
properties would have increased. However, in that case, the reference standard would be 
partially the same as the instrument validated which is methodologically dubious. Moreover, 
there is an on-going discussion regarding the utility of daytime symptoms as a diagnostic 
criterion for OSA. The ICSD-2 definition for OSA opens for a diagnosis of OSA regardless of 
daytime symptoms in persons with an AHI > 15 (Table 1). At the contrary, it has been 
reported that for example hypertension is only related to OSA in persons that experience 
sleepiness (Kapur et al. 2008). Moreover, the first longitudinal study of predictive abilities of 
the BQ reports that BQ high risk predicts death censored graft loss in kidney transplant 
recipients (Szentkiralyi et al. 2011). Thus, although BQ high risk is sub-optimal for 
identifying OSA in the general population, only longitudinal studies can address the 
predicting properties of BQ high risk status in the general population.  
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5.2.2 Prevalence of OSA 
The prevalence of OSA had not previously been estimated in a Norwegian general population. 
The age- and sex specific estimates generated by our statistical model were approximately 
equal to and slightly higher than previous estimates from the Wisconsin Sleep Cohort and 
Pennsylvania State Cohort (Bixler et al. 1998;Bixler et al. 2001;Young et al. 1993), but much 
higher than previous Scandinavian estimates (Gislason et al. 1988;Jennum and Sjol 1992). 
Our estimates were slightly lower than previous estimates from Spain, Poland and Australia 
(Bearpark et al. 1995;Duran et al. 2001;Plywaczewski et al. 2008) and much lower than a 
recent prevalence estimate from Brazil (Tufik et al. 2010). Unfortunately, in many of the 
previous studies the BMI has not been reported. However, according to official statistics from 
the USA and Norway the proportion of adults with obesity has increased by more than 10% 
since the first of these studies was published in 1988 (www.nih.gov, www.fhi.no). It is 
therefore not surprising that the estimated prevalence of OSA in the current study is higher 
than that obtained in older US and Scandinavian estimates. 
In addition to the effect on estimated properties of the BQ as discussed above, the 
choice to define OSA based on a cut-off on the AHI also affected the prevalence estimates 
reported. It would have been possible to calculate prevalences of OSA defined also by 
sleepiness or daytime somnolence. However, I chose not to do so because of multiple factors 
affecting self-reported sleepiness in the general population as revealed in this discussion.   
  Finally, as previously emphasized by Lindberg and Gislason and by Redline et al. 
(Lindberg and Gislason 2000;Redline et al. 2000), analyses by alternative respiratory 
variables than the AHI would have altered the prevalence estimates. For example, if only the 
apnea index had been used for analysis, the prevalence estimates would have been lower. 
Moreover, as indicated in Figure 1, specific focus on central apneas during analyses, 
eventually combined with assessment of venous base deficit or PCO2 could have identified 
obesity hypoventilation syndrome as a specific diagnostic entity within the study population. 
The most recent report of health, social and economical consequences of sleep-disordered 
breathing reported almost threefold costs in patients with obesity hypoventilation syndrome 
when compared to patients with OSA (Jennum and Kjellberg 2011). At the other end of the 
severity scale in Figure 1, scoring of respiratory related arousals would have yielded higher 
prevalence estimates of OSA.      
 5.2.3 OSA severity, verbal memory and executive function 
To my knowledge, no prior study had described verbal memory and executive function in 
community-dwelling adults at high risk of having OSA, as identified by the BQ. Regarding 
associations studied between measures of cognitive function and OSA severity, verbal 
memory was found to be independently related to average oxygen saturation. Executive 
function was not related to any of the pre-defined variables assessing OSA severity. The AHI, 
which is the most commonly used measure when assessing OSA severity, was only related to 
cognitive function in bivariate analyses. The arousal index was not related to cognitive 
function in any analysis. 
The recruitment of participants by the BQ in this study resulted in a clinical sample 
with a relatively low median AHI of 7.7 (25th percentile = 2.4, 75th percentile = 22.2) 
compared with clinical studies of OSA. However, more than one-third of the sample had an 
AHI of t 15, which is the criterion for moderate to severe OSA (American Academy of Sleep 
Medicine 2005). However, as discussed in section 5.2.1, the age- and gender distribution 
within the BQ high risk group might have contributed to a bias towards the null hypothesis 
because persons without OSA were younger and more likely to be female than persons with 
OSA. 
We chose to present raw scores from the RAVLT and the Stroop test followed by 
adjustments in a linear regression model. An alternative approach more easily interpreted by 
clinicians would have been to present norm-based results. However, because cognitive 
function was not assessed in BQ low risk participants, it was chosen to focus on the relation 
between cognitive function and OSA rather than norm-based results. 
Studies in the last five years have confirmed that verbal memory in particular is 
affected by OSA pathology (Naegele et al. 2006;Twigg et al. 2010). On the other hand, the 
association between OSA and the complex executive function may be spurious (Quan et al. 
2006;Saunamaki et al. 2009;Twigg et al. 2010) and potentially influenced by attention 
(Gosselin et al. 2006;Verstraeten and Cluydts 2004).  
Because verbal memory was associated to OSA severity assessed by average oxygen 
saturation but not as assessed by the AHI, it is important to emphasize that average oxygen 
saturation and the AHI had slightly different statistical distributions (figure 5 a and b).  
 
  
Obstructive Sleep Apnea in Community-Dwelling Adults  
61 
 
Figure 5a: Distribution of the apnea hypopnea index (a) and average oxygen saturation 
(b) in the psychosomatic sub-sample 
a      
 
b 
 
  I do not know why the distribution of average oxygen saturation was more bell-shaped 
than the distribution of the AHI. However, this observation indicates that the two measures of 
OSA severity assess slightly different aspects of OSA. In paper II, the possible effect of other 
respiratory disorders than OSA on the oxygen curve is discussed. The conclusion of the 
discussion was that such effects were not likely because the prevalence of other respiratory 
disorders in the sample was low. Our finding of an independent association between average 
oxygen saturation and verbal memory is also in line with a recent study of cerebrovascular 
regulation in community-dwelling adults (Morgan et al. 2010). Thus, although this measure of 
OSA severity does not capture the episodic nature of breathing in OSA, is a promising 
supplement to the AHI in the understanding of OSA pathology.  
In paper II, the relation between average oxygen saturation and verbal memory was 
adjusted for potential confounding by age, gender, higher education and body mass index. 
The model explained 20% of the variance in cognitive function. When MDD or any 
psychiatric disorder was added to the model (data not reported), 21% of the variance was 
explained. Moreover, when psychiatric disorders were entered into the regression models as 
independent variables, they significantly contributed. This finding is in line with the study by 
Cross et al. that reported exacerbated neural injury in OSA patients with depression compared 
to OSA patients without depression (Cross et al. 2008). This indication of an interactive effect 
of depression and OSA on cerebral function may be mediated by metabolic factors or 
systemic inflammation. In another paper from the study sample in paper II and III, we have 
shown an association between high sensitivity C-reactive protein and psychiatric morbidity 
(Einvik et al. 2011). However, it is beyond the scope of this thesis to address this particular 
discussion. Moreover, psychiatric disorders were not entered into the final models of paper II 
because of difficulties in determining the direction of causality between OSA, cognitive 
function and psychiatric disorders. In other words, impaired cognitive function can 
theoretically be both caused by psychiatric disorders and cause psychiatric disorders. 
Accordingly, the association between cognitive function and psychiatric disorders was not 
assessed in this thesis.  
5.2.4 OSA, depression and somatoform pain 
Our finding of a high prevalence of psychiatric disorders in a BQ high-risk sample 
representative of the general population is in line with two previous studies (Hiestand et al. 
2006;Kapsimalis and Kryger 2009). The study by Hiestand et al. reported a prevalence of 
depression in 33.0% and anxiety in 18% of BQ high risk respondents of the 2005 “Sleep in 
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America poll”. The study by Kapsimalis et al. reported a prevalence of depression in 41.0% 
and anxiety in 22% of BQ high risk female respondents of the 2007 poll (Kapsimalis and 
Kryger 2009). These proportions were based on self-report of psychiatric diagnoses, which 
can explain the somewhat higher estimates than those reported in our study. 
 In addition to a high prevalence of psychiatric disorders, Figure 6 demonstrates a high 
degree of co-morbidity between different psychiatric disorders in the psychosomatic sample. 
 
Figure 6: Co-morbidity between psychiatric disorders 
 
 
 
The co-morbidity illustrated in the figure is in line with previous studies of psychiatric 
disorders in the general population at the time of planning this thesis (Wittchen and Jacobi 
2005). A recent update of this review also included sleep disorders to the size and burden of 
mental disorders in Europe (Wittchen et al. 2011). In this review, the prevalence of mental 
disorders changed to a minor extent. However, nonorganic insomnia was found to be present 
in 7% and OSA in 3% of the general European population. Thus, in addition to the co-
morbidity displayed in Figure 6, there is probably also an overlap between OSA and insomnia 
that has not been emphasized in this thesis (Bjornsdottir et al. 2012).    
Regarding the association between OSA and psychiatric disorders, the findings that 
neither of MDD, current anxiety and somatoform pain disorder were associated with OSA has 
important implications for the interpretation of previous studies that have reported positive 
 associations between OSA and symptoms of psychiatric disorders (Aikens and Mendelson 
1999;Bardwell et al. 1999;Kales et al. 1985;Sharafkhaneh et al. 2005). Most community-
based studies of this relationship have concluded that OSA seems to be an independent risk 
factor for symptoms of depression as assessed by questionnaires (Ohayon 2003;Peppard et al. 
2006;Sivertsen et al. 2008). In contrast, our data support community-based studies that have 
partly or completely failed to establish an independent association between OSA and 
depression (Enright et al. 1996;Kripke et al. 1997). However, only two previous, community-
based studies concerning the relation between OSA and depression have assessed sleep with 
objective measures (Kripke et al. 1997;Peppard et al. 2006). In a sample with median 4% 
oxygen desaturation index of 4.3 in females and 6.7 in males, Kripke et al. found no 
association between symptoms of depression and OSA (Kripke et al. 1997). In contrast, 
Peppard et al. using a sample in which 6% of the females and 14% of the males showed an 
AHI ≥ 15, found a positive dose-response association between SRBD and depression 
(Peppard et al. 2006). The severity of OSA in our BQ high risk sample was higher than in 
these samples. Moreover, as presented in an on-line supplement to paper III (appendix 9), 
alternative definitions of OSA did only result in minor changes to our findings.  
 The association between OSA and symptoms of depression was also assessed in an 
auxiliary sample consisting of all BQ low risk participant in the ASAP. These analyses 
revealed that both the mean BDI sum and the median AHI were 50% lower than in the BQ 
high risk sample. Moreover, also in this BQ low risk sample, BDI scores did not differ 
significantly between those with OSA and those without OSA. Consequently these findings 
from the auxiliary sample imply that the high level of psychiatric co-morbidity observed 
among BQ high risk participants more likely is related to properties of the BQ rather than 
being an effect of OSA as such. This interpretation is in line with Andrews et al. who 
hypothesized that shared co-factors between depression and OSA rather than apneas and 
hypopneas per se explain the association between OSA and symptoms of depression found in 
multiple studies of clinical samples (Andrews and Oei 2004). Moreover, in the study by 
Peppard et al. (Peppard et al. 2006), also important effects of putative confounders on the said 
association were reported. We therefore believe that our findings contribute to an elucidation 
of the complex association between OSA, psychiatric disorders and cardinal symptoms of 
OSA.  
 Finally, in line with a recent review of epidemiology of OSA, the estimation of a 
high prevalences of OSA with subsequent sub-optimal screening properties of the BQ in a 
general population sample emphasizes the need for improved screening models for OSA and 
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sleep-disordered breathing (Jennum and Riha 2009). Moreover, the finding of an association 
between average oxygen saturation and verbal memory and the finding of a negative 
association between any psychiatric disorder and OSA among persons with BQ high risk in 
the general population are reminders of the complexity of these associations. This complexity 
ranges from “various circumstances” causing selection bias to studies of clinical populations 
to the distribution of screening factors for OSA in community-based studies of OSA. 
Accordingly, clinicians treating OSA need to carefully evaluate the effect of these “various 
circumstances,” such as age, sex, obesity, psychiatric disorders, cognitive functioning and 
effects of everyday distress when confronted with the patient with OSA.  
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6.0.0 Conclusion and clinical implications 
This thesis has focused on screening properties of the BQ, prevalence of OSA, cognitive 
function and psychiatric disorders. The following conclusions are drawn: 
x One out of four respondents of the BQ was classified at high risk of having OSA. 
However, the screening properties of the BQ were sub-optimal.  
x The prevalences of OSA defined by AHI ≥ 5 and by AHI ≥ 15 in a Norwegian general 
population sample were estimated to be 16% and 8% respectively.  
x Cognitive test scores from participants with high risk for OSA were comparable to 
scores of persons 20-30 years older than the age of the participants. 
x An independent association between verbal memory and OSA severity as assessed by 
average oxygen saturation was found. 
x MDD, current anxiety disorder and somatoform pain disorder were diagnosed in 
12.4%, 14.8% and 19.3% of community-dwelling adults at a high risk for OSA.  
x A negative association between OSA and psychiatric morbidity was found.  
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7.0.0 Suggestions for future research 
x No previous study has validated screening properties of the BQ in a general population 
sample. Therefore, our findings should ideally be replicated in future community-
based studies. However, we believe that future studies assessing properties of the BQ 
in the general population should modify the scoring algorithm, alternatively assess 
predictive power of single items or combinations of items. Moreover, the items 
assessing daytime somnolence should be more precisely formulated or simply 
replaced by the ESS. Finally, as a result of the findings presented in paper III, 
assessment of daytime somnolence in the BQ should optimally be weighted according 
to level of psychiatric co-morbidity.  
x This thesis has presented the first, Norwegian prevalence estimate of OSA. Thus, our 
baseline assessment is suitable for studying the incidence of OSA in the future. 
x The novel finding of average oxygen saturation being the most important assessment 
of OSA severity on cognitive function should be replicated in future studies. 
Moreover, associations between average oxygen saturation, symptoms and other 
features of OSA than cognitive function should be further clarified.   
x Future research should explore potential biomarkers related to variables assessing 
OSA severity, cognitive function and psychiatric disorders. In particular, interactive 
effects of psychiatric morbidity and OSA should be explored in relation to metabolic 
disturbancies or systemic inflammation. 
x More focus should be given to other forms of psychiatric co-morbidity in OSA than 
depression. In particular somatoform pain, anxiety and insomnia should be explored.  
x Information regarding shift work was not registered in this study and collected data 
regarding perception of sleep complaints, insomnia and sleep related quality of life 
have not yet been analyzed. These aspects might have given additional information in 
interpreting sleep variables and should be included in future studies of cognitive 
function, psychiatric disorders or subjective daytime complaints related to OSA. 
x Finally, the baseline examinations of the ASAP consist of an extensive baseline 
assessment of 535 participants. A goal for future research on the properties of the BQ 
will be to follow these 535 participants through life.
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9.0.0 Appendices 
 
Appendix 1: DSM IV criteria for major depression 
A. Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed 
mood or (2) loss of interest or pleasure. 
Note:  Do note include symptoms that are clearly due to a general medical condition, or mood-
incongruent delusions or hallucinations. 
 
(1) depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., 
feels sad or empty) or observation made by others (e.g., appears tearful).  
 
(2) markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly 
every day (as indicated by either subjective account or observation made by others) 
 
(3) significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body 
weight in a month), or decrease or increase in appetite nearly every day.  
(4) insomnia or hypersomnia nearly every day 
 
(5) psychomotor agitation or retardation nearly every day (observable by others, not merely 
subjective feelings of restlessness or being slowed down) 
 
(6) fatigue or loss of energy nearly every day 
 
(7) feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly 
every day (not merely self-reproach or guilt about being sick) 
 
(8) diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective 
account or as observed by others) 
 
(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific 
plan, or a suicide attempt or a specific plan for committing suicide  
B. The symptoms do not meet criteria for a Mixed Episode. 
 
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. 
 
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, 
a medication) or a general medical condition (e.g., hypothyroidism). 
 
E. The symptoms are not better accounted for by bereavement, i.e., after the loss of a loved one, the 
symptoms persist for longer than 2 months or are characterized by marked functional impairment, 
morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or psychomotor 
retardation. 
 
 Appendix 2: DSM-IV criteria for anxiety disorders 
Generalized Anxiety Disorder 
1. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at 
least six months, about a number of events or activities (such as work or school 
performance).  
2. The person finds it difficult to control the worry.  
3. The anxiety and worry are associated with three (or more) of the following six symptoms 
(with at least some symptoms present for more days than not for the past 6 months). Note: 
Only one item is required in children.  
1. restlessness or feeling keyed up or on edge  
2. being easily fatigued  
3. irritability  
4. muscle tension  
5. difficulty falling or staying asleep, or restless unsatisfying sleep  
6. difficulty concentrating or the mind going blank  
Symptoms can also include nausea, vomiting, and chronic stomach aches. 
1. The focus of the anxiety and worry is not confined to features of an Axis I disorder, e.g., the 
anxiety or worry is not about having a panic attack (as in panic disorder), being embarrassed 
in public (as in social phobia), being away from home or close relatives (as in Separation 
Anxiety Disorder), gaining weight (as in anorexia nervosa), having multiple physical 
complaints (as in somatization disorder), or having a serious illness (as in hypochondriasis), 
and the anxiety and worry do not occur exclusively during post-traumatic stress disorder.  
2. The anxiety, worry, or physical symptoms cause clinically significant distress or impairment 
in social, occupational, or other important areas of functioning.  
3. The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of 
abuse, a medication) or a general medical condition (e.g., hyperthyroidism) and does not 
occur exclusively during a Mood Disorder, a Psychotic Disorder, or a Pervasive 
Developmental Disorder.  
Panic disorder with (or without) agoraphobia: 
A. Both (1) and (2):  
1. recurrent unexpected panic attacks  
2. at least one of the attacks has been followed by 1 month (or more) of one (or more) of the 
following:  
x persistent concern about having additional attacks  
x worry about the implications of the attack or its consequences (e.g., losing control, having a 
heart attack, "going crazy")  
x significant change in behavior related to the attacks  
B. The presence (or absence) of agoraphobia  
C. The panic attacks are not due to the direct physiological effects of a substance (e.g., a drug of 
abuse, a medication) or a general medical condition (e.g., hyperthyroidism).  
D. The panic attacks are not better accounted for by another mental disorder, such as social phobia 
Obstructive Sleep Apnea in Community-Dwelling Adults  
85 
(e.g., occurring on exposure to feared social situations), specific phobia (e.g., on exposure to a 
specific phobic situation), obsessive-compulsive disorder (e.g., on exposure to dirt in someone with 
an obsession about contamination), post-traumatic stress disorder (e.g., in response to stimuli 
associated with a severe stressor), or separation anxiety disorder (e.g., in response to being away from 
home or close relatives).  
 
Social Phobia (300.23) 
A. A marked and persistent fear of one or more social or performance situations in which the person 
is exposed to unfamiliar people or to possible scrutiny by others. The individual fears that he or she 
will act in a way (or show anxiety symptoms) that will be humiliating or embarrassing.  
Note: In children, there must be evidence of the capacity for age-appropriate social relationships with 
familiar people and the anxiety must occur in peer settings, not just in interactions with adults.  
B. Exposure to the feared social situation almost invariably provokes anxiety, which may take the 
form of a situationally bound or situationally predisposed Panic Attack. Note: In children, the anxiety 
may be expressed by crying, tantrums, freezing, or shrinking from social situations with unfamiliar 
people.  
C. The person recognizes that the fear is excessive or unreasonable. Note: In children, this feature 
may be absent.  
D. The feared social or performance situations are avoided or else are endured with intense anxiety or 
distress.  
E. The avoidance, anxious anticipation, or distress in the feared social or performance situation(s) 
interferes significantly with the person's normal routine, occupational (academic) functioning, or 
social activities or relationships, or there is marked distress about having the phobia.  
F. In individuals under age 18 years, the duration is at least 6 months.  
G. The fear or avoidance is not due to the direct physiological effects of a substance (e.g., a drug of 
abuse, a medication) or a general medical condition and is not better accounted for by another mental 
disorder (e.g., Panic Disorder With or Without Agoraphobia, Separation Anxiety Disorder, Body 
Dysmorphic Disorder, a Pervasive Developmental Disorder, or Schizoid Personality Disorder).  
H. If a general medical condition or another mental disorder is present, the fear in Criterion A is 
unrelated to it, e.g., the fear is not of Stuttering, trembling in Parkinson's dsease, or exhibiting 
abnormal eating behavior in Anorexia Nervosa or Bulimia Nervosa.  
Specify if: Generalized: if the fears include most social situations (also consider the additional 
diagnosis of Avoidant Personality Disorder) 
 
Obsessive Compulsive Disorder 
Obsessions  
 1. Recurrent and persistent thoughts, impulses, or images that are experienced as intrusive and 
that cause marked anxiety or distress.  
2. The thoughts, impulses, or images are not simply excessive worries about real-life problems.  
3. The person attempts to ignore or suppress such thoughts, impulses, or images, or to neutralize 
them with some other thought or action.  
4. The person recognizes that the obsessional thoughts, impulses, or images are a product of his 
or her own mind, and are not based in reality.  
Compulsions  
1. Repetitive behaviors or mental acts that the person feels driven to perform in response to an 
obsession, or according to rules that must be applied rigidly.  
2. The behaviors or mental acts are aimed at preventing or reducing distress or preventing some 
dreaded event or situation; however, these behaviors or mental acts are not actually connected 
to the issue, or they are excessive.  
In addition to these criteria, at some point during the course of the disorder, the individual must 
realize that his/her obsessions or compulsions are unreasonable or excessive. Moreover, the 
obsessions or compulsions must be time-consuming (taking up more than one hour per day), cause 
distress, or cause impairment in social, occupational, or school functioning.[4] OCD often causes 
feelings similar to those of depression. 
PTSD 
A. Exposure to a traumatic event  
B. Persistent reexperience (e.g. flashbacks, nightmares)  
C. Persistent avoidance of stimuli associated with the trauma (e.g. inability to talk about 
things even related to the experience, avoidance of things and discussions that trigger 
flashbacks and reexperiencing symptoms fear of losing control)  
D. Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger 
and hypervigilance)  
E. Duration of symptoms more than 1 month  
F. Significant impairment in social, occupational, or other important areas of functioning (e.g. 
problems with work and relationships.)  
Notably, criterion A (the "stressor") consists of two parts, both of which must apply for a diagnosis of 
PTSD. The first (A1) requires that "the person experienced, witnessed, or was confronted with an 
event or events that involved actual or threatened death or serious injury, or a threat to the physical 
integrity of self or others." 
The second (A2) requires that "the person’s response involved intense fear, helplessness, or horror."  
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Appendix 3: Descriptions of DSM-IV Somatoform disorders assessed 
Hypochondriasis 
Preoccupation with fears of having a serious disease based upon a misinterpretation of bodily 
sensations. The preoccupation exists despite assurance from a physician that the individual does not 
have a serious disease. 
 
Somatoform pain disorder:  
Pain which causes significant distress or impairment in functioning which cannot be fully explained 
by a physician. It must be judged to be related to psychological factors and cannot be better explained 
by another disorder. 
 
Diagnostic criteria: 
A. Pain in one or more anatomical sites is the predominant focus of the clinical 
presentation and is of sufficient severity to warrant clinical attention 
B. The pain causes clinically significant distress or impairment in social, occupational, 
or other important areas of functioning.  
C. Psychological factors are judged to have an important role in the onset, severity, 
exacerbation or maintenance of the pain 
D. The symptom or deficit is not intentionally produced or feigned  
E. The pain is not better accounted for by a Mood, Anxiety, or Psychotic Disorder and 
does not meet criteria for Dyspareunia 
 
Somatization disorder 
Includes a history of physical complaints prior to age 30 which occur over a period of several years. 
There must be a significant impairment in functioning or a history of resulting medical treatment. 
After appropriate assessment by a physician, there is a lack of explanation of the reported symptoms 
or for at least the severity of the complaints. 
 
 
 Appendix 4: Response rates 
 
Age category Female response rates Male response rates 
30 49.0 38.7 
35 52.7 42.5 
40 57.8 50.6 
45 57.0 51.7 
50 63.1 54.1 
55 64.3 58.9 
60 64.3 60.0 
65 67.8 70.7 
Total 59.0 52.4 
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Appendix 5: Scoring algorithm for the Berlin Questionnaire 
 
Adapted from: Table 2 from Netzer, et al., 1999. (Netzer NC, Stoohs RA, Netzer CM, Clark K, 
Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea 
syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91). 
The questionnaire consists of 3 categories related to the risk of having sleep apnea. 
Patients can be classified into High Risk or Low Risk based on their responses to the 
individual items and their overall scores in the symptom categories. 
Categories and scoring: 
Category 1: items 1, 2, 3, 4, 5. 
Item 1: if ‘Yes’, assign 1 point 
Item 2: if ‘c’ or ‘d’ is the response, assign 1 point 
Item 3: if ‘a’ or ‘b’ is the response, assign 1 point 
Item 4: if ‘a’ is the response, assign 1 point 
Item 5: if ‘a’ or ‘b’ is the response, assign 2 points 
Add points. Category 1 is positive if the total score is 2 or more points 
Category 2: items 6, 7, 8 (item 9 should be noted separately). 
Item 6: if ‘a’ or ‘b’ is the response, assign 1 point 
Item 7: if ‘a’ or ‘b’ is the response, assign 1 point 
Item 8: if ‘a’ is the response, assign 1 point 
Add points. Category 2 is positive if the total score is 2 or more points 
Category 3 is positive if the answer to item 10 is ‘Yes’ OR if the BMI of the 
patient is greater than 30kg/m2. 
(BMI must be calculated. BMI is defined as weight (kg) divided by height (m) 
squared, i.e., kg/m2). 
High Risk: if there are 2 or more Categories where the score is positive 
Low Risk: if there is only 1 or no Categories where the score is positive 
Additional question: item 9 should be noted separately. 
 
  Appendix 6: The screening questionnaire 
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Appendix 7: The Beck Depression Inventory 
 
I dette spørreskjemaet vil du finne setninger inndelt i grupper. Vennligst les alle setningene innenfor hver 
gruppe nøye. Deretter velger du den setningen i hver gruppe som best beskriver hvordan du har følt deg 
DEN SISTE UKA, I DAG INKLUDERT. Du kan krysse av på flere alternativer innenfor samme gruppe. 
 
Husk å lese alle setningene innenfor en gruppe før du velger, og pass på at du gir svar innenfor alle 
gruppene.  
 
 
A 
 Jeg føler meg ikke trist 
 Jeg er lei meg eller føler meg trist 
 Jeg er lei meg eller trist hele tiden og kan ikke komme ut av denne tilstand 
 Jeg er så trist og ulykkelig at jeg ikke holder det ut 
B 
 Jeg er ikke særlig pessimistisk eller motløs overfor fremtiden 
 Jeg føler meg motløs overfor fremtiden 
 Jeg føler at jeg ikke har noe å se frem til 
 Jeg føler at fremtiden er håpløs og at forholdene ikke kan bedre seg 
C 
 Jeg føler meg ikke som et mislykket menneske 
 Jeg føler at jeg har mislyktes mer enn andre mennesker 
 Når jeg ser tilbake på livet mitt, ser jeg ikke annet enn mislykkethet 
 Jeg føler at jeg har mislykkes fullstendig som menneske 
D 
 Jeg får like mye tilfredsstillelse ut av ting som før 
 Jeg nyter ikke ting på samme måte som før 
 Jeg får ikke ordentlig tilfredsstillelse ut av noe lenger 
 Jeg er misfornøyd eller kjeder meg med alt 
E  
 Jeg føler meg ikke særlig skyldbetynget 
 Jeg føler meg skyldbetinget en god del av tiden 
 Jeg føler meg temmelig skyldbetynget mesteparten av tiden 
 Jeg føler meg skyldbetinget hele tiden 
F 
 Jeg har ikke følelsen av å bli straffet 
 Jeg føler at jeg kan bli straffet 
 Jeg forventer å bli straffet 
 Jeg føler at jeg blir straffet 
 
 
 
 
 
 
 
 G 
 Jeg føler meg ikke skuffet over meg selv 
 Jeg er skuffet over meg selv 
 Jeg avskyr meg selv 
 Jeg hater meg selv 
H 
 Jeg føler ikke at jeg er noe dårligere enn andre 
 Jeg kritiserer meg selv for mine svakheter eller feilgrep 
 Jeg bebreider meg selv hele tiden for mine feil eller mangler 
 Jeg gir meg selv skylden for alt galt som skjer 
I 
 Jeg har ikke tanker om å ta livet mitt 
 Jeg har tanker om å ta livet mitt, men jeg vil ikke omsette dem i handling 
 Jeg ønsker å ta livet mitt 
 Jeg ville tatt livet mitt om jeg fikk sjansen til det 
J 
 Jeg gråter ikke mer enn vanlig 
 Jeg gråter mer nå enn jeg gjorde før 
 Jeg gråter hele tiden nå  
 Jeg pleide å kunne gråte, men nå kan jeg ikke gråte selv om jeg gjerne vil 
K 
 Jeg er ikke mer irritert nå enn ellers 
 Jeg blir lettere ergerlig eller irritert enn før 
 Jeg føler meg irritert hele tiden nå 
 Jeg blir ikke irritert i det hele tatt over ting som pleide å irritere meg 
L 
 Jeg har ikke mistet interessen for andre mennesker 
 Jeg er mindre interessert i andre mennesker enn jeg pleide å være 
 Jeg har mistet det meste av min interesse for andre mennesker  
 Jeg har mistet all interesse for andre mennesker  
M 
 Jeg tar avgjørelser omtrent like lett som jeg alltid har gjort 
 Jeg forsøker å utsette det å ta avgjørelser mer enn tidligere 
 Jeg har større vanskeligheter med å ta avgjørelser enn før 
 Jeg klarer ikke å ta avgjørelser i det hele tatt lenger 
 
N 
 Jeg føler ikke at jeg ser dårligere ut enn jeg pleide å gjøre 
 Jeg er redd for at jeg ser gammel eller lite tiltrekkende ut 
 Jeg føler at det er varige forandringer i mitt utseende som får meg til å se lite tiltrekkende 
ut 
 Jeg tror at jeg ser stygg ut 
O 
 Jeg kan arbeide omtrent like godt som før 
 Det kreves ekstra anstrengelse for å ta fatt på noe 
 Jeg må presse meg hardt for å gjøre noe  
 Jeg klarer ikke å gjøre noe arbeid i det hele tatt 
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P 
 Jeg sover like godt som ellers 
 Jeg sover ikke så godt som før 
 Jeg våkner 1-2 timer tidligere enn ellers og har vanskelig for å sovne igjen 
 Jeg våkner flere timer tidligere enn jeg pleide og får ikke sove igjen 
Q 
 Jeg blir ikke fortere trett enn ellers 
 Jeg blir fortere trett enn ellers 
 Nesten alt jeg gjør blir jeg trett av 
 Jeg er for trett til å gjøre noe som helst 
R 
 Matlysten min er ikke dårligere enn ellers 
 Matlysten er ikke så god som den var før 
 Matlysten min er mye dårligere nå 
 Jeg har ikke mye matlyst i det hele tatt lenger 
S 
 Jeg har ikke gått ned meget i vekt, om i det hele tatt noe, i den senere tid 
 Jeg har tatt av mer enn 2 kg 
 Jeg har tatt av mer enn 4 kg 
 Jeg har tatt av mer enn 6 kg 
T 
 Jeg er ikke mer bekymret for helsen min enn vanlig 
 Jeg er bekymret over fysiske plager som verking og smerter; eller urolig mage, eller 
forstoppelse 
 Jeg er meget bekymret over fysiske plager, og det er vanskelig å tenke på stort annet 
 Jeg er så bekymret over mine fysiske plager, at jeg ikke klarer å tenke på noe annet 
U 
 Jeg har ikke merket noen forandring i mine seksuelle interesser i det siste 
 Jeg er mindre interessert i sex enn jeg var før  
 Jeg er mye mindre interessert i sex nå 
 Jeg har helt mistet interessen for sex 
  
 Appendix 8: Online supplement to paper I 
 
Estimated screening properties of the Berlin Questionnaire (BQ) and prevalences of 
Obstructive Sleep Apnea (OSA) 
The data sample for the clinical phase consisted of 518 subjects: 153 in the BQ low-risk group 
and 365 in the BQ high-risk group. We assumed that the BQ high risk group, which was 
randomly drawn from screening-phase subjects, was representative of BQ high risk subjects in 
the screening sample. However, empirical analyses showed that the BQ low risk group group of 
153 subjects would result in biased estimates because of exclusion of 5541 questionnaires with 
missing BQ values. Therefore, we first calculated pretest probabilities for each stratum of the BQ 
high risk and BQ low risk groups separately. Second, the resulting stratum-specific BQ high risk 
and BQ low risk estimates were combined using weighted averages. 
 
1: Prevalences of OSA in the clinical sample 
Unadjusted prevalences for each stratum were estimated for the 518 subjects available. Then, 
weights ( hW , h  being the stratum indicator) were defined as the ratio of a particular strata size in 
the population ( hN ) to the total of the population ( N ), i.e., N
NW hh  . A weighted pretest 
probability was calculated for each stratum as suggested by Cochran (W.G.Cochran 1963): 
¦ 
h
hh pWprev , where hp  is the proportion of subjects with an apnea–hypopnea index (AHI) 
greater than the cutoff value in stratum h . The variance of the estimated prev  was then defined 
as      ¦  h h hhh hhh n
pp
N
nNN
N
prevVar
1
1
1
1 2
2 , where hn  is the number of sampled subjects in 
stratum h . 
 
2: Adjustment for participation status in the statistical sample 
Stratum-specific pretest probabilities were adjusted for participation status based on the 
remaining 1254 subjects drawn but not included in the clinical sample using a logistic regression 
model. On the basis of the 518 cases included in the clinical sample of the study, we fitted a 
logistic regression model for AHI cutoff values of 5 and 15. Items from the BQ, items assessing 
comorbidity and dummy variables for each stratum were considered. Because of too many 
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missing values or high p-values in univariate analyses, only the BQ snoring category variable, 
obesity, defined as a body mass index > 30, self-reported hypertension and strata dummies were 
left in the final multivariate logistic regression model. According to standard diagnostic tests, the 
model was of good quality. Therefore, we used the model to predict the probability of an AHI 
above the cutoff value for subjects that were drawn but not included in the clinical phase. As the 
estimated probabilities within each stratum were rather homogeneous as indicated by a low 
variance, they were grouped by averaging them separately for each stratum. These averaged 
probabilities were then used as estimates for prevalences for all 1772 subjects drawn and were 
weighted using the previously defined strata weights. 
To evaluate the reliability of the regression model, we first compared observed and 
estimated crude prevalences for OSA defined by the AHI cut-off values using a sample of 518. 
Estimated prevalences were nearly identical to the observed data for each stratum, indicating that 
the model predicted well within the study sample. As the same model was intended to be used for 
extrapolating the estimates for the estimation sample of the study, we also simulated the 
probability of an AHI above the cut off for different strata with the assumption that the estimated 
regression model was correct. The simulated prevalences, calculated from 100 iterations, were 
also nearly identical to the observed prevalences and consequently, the estimated prevalences in 
each stratum for the 518 subjects. The 100 iterations were then used to estimate the screening 
properties of the BQ. As the explanatory variables preserved the form of the corresponding 
distributions for subjects drawn but not included in the clinical phase, we concluded that the same 
regression model could also be used to predict prevalences and screening properties when 
extrapolating the results to the screening sample. 
 Prevalences for subjects drawn and included in the clinical sample and for subjects drawn 
and not included in the clinical sample were combined by calculating a weighted average for 
these two groups separately for each stratum. Weights were defined by strata sizes for each 
group. The adjustment for bias in the BQ low risk group was performed in the same manner 
using the estimated probabilities.  
The final estimates of screening properties of the BQ and prevalences of OSA in the 
general population were obtained using the formula presented above and are presented in table 3-
4 in the main article. Comprehensive estimates of BQ screening properties are presented in table 
E1. 
  
Table E1: Final estimates of screening properties of the BQ 
 
AHI5 (area under the receiver operater curve for the model = 0.87) 
 Empirical – 518 Simulated – 518 Simulated – 14,687* 
Sensitivity 79.4 79.7 37.2 (36.0–38.4) 
Specificity 40.5 40.8 84.0 (83.2–84.7) 
PPV 62.2 62.1 61.3 (59.7–62.9) 
NPV 61.4 62.3 66.2 (65.3–67.1) 
LR+ 1.3 1.4 2.32 (2.19–2.46) 
LR- 0.5 0.5 0.75 (0.73–0.76) 
OR 2.6 2.8 3.1 (2.9–3.4) 
 
AHI15 (area under the receiver operater curve for the model = 0.74) 
 Empirical – 518 Simulated – 518 Simulated – 14,687* 
Sensitivity 82.8 83.1 43.0 (41.2–44.8) 
Specificity 34.9 35.0 79.7 (79.0–80.5) 
PPV 35.6 35.5 33.5 (32.0–35.0) 
NPV 82.4 82.8 85.5 (84.8–86.1) 
LR+ 1.3 1.3 2.12 (2.01–2.25) 
LR- 0.5 0.5 0.72 (0.69–0.74) 
OR 2.6 2.8 3.0 (2.7–3.2) 
AHI = apnea–hypopnea index  
*The simulated screening sample consisted of 14.687 subjects consisting of the 9319 subjects 
eligible for the clinical sample plus the 5671 BQ low risk subjects with missing BQ items minus 
173 subjects with missing variables used in the model.  
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Appendix 9: Online supplement from paper III 
 
Sleep apnoea, anxiety, depression and somatoform pain: A community-based high risk 
sample 
Supplementary material  
 
TABLE S1. Prevalence of current psychiatric disorders and differences between participants 
with and without obstructive sleep apnoea (apnoea hypopnoea index ≥ 15) by chi-square test 
(N = 289) 
 
 OSA 
N = 104 
No OSA 
N =185 
P-value 
Affective disorders    
Major depressive disorder 8 (7.7) 27 (14.6) 0.089 
Dysthymia 3 (2.9) 2 (1.1) 0.355a 
Current affective disorder  10 (9.6) 29 (15.7) 0.148 
Anxiety disorders    
Current panic disorder 5 (4.8) 12 (6.5) 0.560 
Agoraphobia without panic disorder 1 (1.0) 1 (0.5) 1.000a 
Social phobia 5 (4.8) 8 (4.3) 1.000a 
Obsessive–compulsive disorder 1 (1.0) 4 (2.2) 0.657a 
Post-traumatic stress disorder 3 (2.9) 13 (7.0) 0.139 
Generalised anxiety disorder 5 (4.8) 9 (4.9) 0.983 
Current anxiety  13 (12.5) 30 (16.2) 0.394 
Alcohol and substance abuse    
Current alcohol abuse 2 (1.9) 3 (1.6) 1.000a 
Somatoform disorders    
Hypochondriasis 1 (1.0) 2 (1.1) 1.000a 
Somatoform pain disorder 16 (15.4 ) 40 (21.6) 0.198 
Somatisation disorder 2 (1.9) 7 (3.8) 0.497a 
Current somatoform disorder 17 (16.3) 41 (22.2) 0.236 
Any psychiatric disorderb 33 (31.7) 76 (41.1) 0.115 
 
Results are presented as number and percent of participants with disorder(s). 
a = Fisher’s exact test 
Interrater reliability was tested for disorders written in bold. 
b = Any one or more of the psychiatric disorders listed in the table 
 
 
 TABLE S2. Prevalence of current psychiatric disorders and differences between participants 
with and without obstructive sleep apnoea (apnoea hypopnoea index ≥ 30) by chi-square test 
(N = 289) 
 
 OSA 
N = 56 
No OSA 
N =233 
P-value 
Affective disorders    
Major depressive disorder 5 (8.9) 30 (12.9) 0.416 
Dysthymia 1 (1.8) 4 (1.7) 1.000a 
Current affective disorder  6 (10.7) 33 (14.2) 0.498 
Anxiety disorders    
Current panic disorder 2 (3.6) 15 (6.4) 0.541a 
Agoraphobia without panic disorder 0 (0.0) 2 (0.9) 1.000a 
Social phobia 4 (7.1) 9 (3.9) 0.287a 
Obsessive–compulsive disorder 1 (1.8) 4 (1.7) 1.000a 
Post-traumatic stress disorder 0 (0.0) 16 (6.9) 0.048a 
Generalised anxiety disorder 0 (0.0) 14 (6.0) 0.080a 
Current anxiety  6 (10.7) 37 (15.9) 0.329 
Alcohol and substance abuse    
Current alcohol abuse 1 (1.8) 4 (1.7) 1.000a 
Somatoform disorders    
Hypochondriasis 0 (0.0) 3 (1.3) 1.000a 
Somatoform pain disorder 8 (14.3) 48 (20.6) 0.283 
Somatisation disorder 1 (1.8) 8 (3.4) 1.000a 
Current somatoform disorder 8 (14.3) 50 (21.5) 0.229 
Any psychiatric disorderb 17 (30.4) 92 (39.5) 0.206 
 
Results are presented as number and percent of participants with disorder(s). 
a = Fisher’s exact test 
Interrater reliability was tested for disorders written in bold. 
b = Any one or more of the psychiatric disorders listed in the table 
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Abstract
Purpose Cognitive functions in community-dwelling adults
at high risk of obstructive sleep apnea have not been
described and nor are associations between cognitive
functions and obstructive sleep apnea severity fully under-
stood. The study aimed to describe verbal memory and
executive function in community-dwelling adults identified
by the Berlin Questionnaire and to investigate associations
between these cognitive domains and different obstructive
sleep apnea severity indicators.
Methods Among 29,258 age- and gender-stratified persons
30–65 years who received the Berlin Questionnaire by
mail, 16,302 (55.7%) responded. From 654 randomly
drawn respondents with BQ high risk who were
approached for study participation, 290 participants
(55.9% males, mean age 48.2 years) were included.
Verbal memory was assessed by Rey Auditory Verbal
Learning Test and executive function by Stroop test.
Obstructive sleep apnea severity indicators were assessed
by polysomnography.
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Results Mean (standard deviation) verbal learning score
was 42.0 (8.9), mean interference time was 31.1 (12.7),
median (25th percentile, 75th percentile) apnea–hypopnea
index was 7.7 (2.4–22.2), and mean average oxygen
saturation was 94.3 (2.0). Verbal learning score was
independently associated with average oxygen saturation
(β=0.721, p=0.025) in multivariate linear regression
models adjusted for putative confounders. Interference time
was only related to OSA severity indicators in bivariate
analyses.
Conclusions Verbal memory and executive function
impairments were mild in community-dwelling adults at
high risk of obstructive sleep apnea. Average oxygen
saturation was the indicator of obstructive sleep apnea
severity most strongly associated with cognitive function.
Keywords Neurobehavioural manifestations .
Polysomnography . Epidemiology . Sleep apnea
syndromes . Sleep disordered breathing
Introduction
The association between moderate to severe obstructive sleep
apnea (OSA) and impaired neurocognitive function is well-
established [1–6]. It is unclear whether this association is
related to intermittent oxygen desaturations or the repeated
arousals of OSA [1–6]. Neurocognitive function consists of
basal processes (i.e., attention, motor speed, and vigilance)
and more differentiated cognitive functions, of which
impairments in verbal memory [7, 8] and executive
functioning [9–11] have been found to be most strongly
related to OSA. However, findings of cognitive impairments
in patients with moderate to severe OSA have not been
consistently reproduced in community-based studies.
We identified seven community-based studies [12–18] and
two studies of mild OSA in volunteers [19, 20] that assessed
cognitive function with rater-administered instruments in
addition to objective sleep measures. Four studies reported
associations between OSA and at least one cognitive domain
[13, 14, 19, 20]. Affected cognitive domains were verbal
memory (Wechsler Memory Scale [13], declarative memory
factor [20]), and working memory (composite factor [20]),
spatial orientation (Clock Test [13]), executive function
(Wechsler Adult Intelligence Scale-Revised Digits Backward
Subtest [19]), and cerebral efficiency (composite factor [14]).
Five of the identified studies reported analyses by variables
assessing oxygen saturation (4% oxygen desaturation index,
lowest oxygen saturation, or percentage time below 90%
oxygen saturation [13, 16–18, 20]). In all these studies, the
associations with oxygen saturation were at least as strong as
the associations reported between cognitive functions and
apnea–hypopnea indices (AHIs). The average oxygen
saturation during sleep has recently been associated with
cerebrovascular regulation in community-dwelling adults
[21]. None of the identified community-based studies
reported analyses by the arousal index.
In addition to the question of which mechanisms of OSA
are associated with cognitive impairment, the relative impor-
tance of sociodemography and other potential health-related
factors, such as alcohol abuse, sleepiness, use of hypnoseda-
tives, smoking, and asthma [15–17, 19, 20], are not fully
understood. The present study is unique in terms of
including a large, community-based sample of participants
identified by the Berlin Questionnaire (BQ) [22] as being at
risk of OSA. The BQ is a widely used screening tool for
OSA that has been used as a proxy for OSA diagnosis in
nationwide US telephone surveys [23, 24] and validated in
the Norwegian general population [25]. We are not aware of
any study of cognitive function in a strictly defined
probability sample of OSA. We aimed to (1) characterize
cognitive function among community-based, BQ high-risk
participants; and (2) investigate associations between verbal
memory, executive function, and OSA severity as assessed
by the AHI, indicators of oxygen saturation, and the arousal
index before and after adjustment for putative confounders
such as age, gender, comorbid conditions (alcohol abuse,
asthma), use of hypnosedatives, sleepiness, smoking, and
educational level. We hypothesized that verbal memory and
executive function would be more closely related to
variables assessing oxygen saturation than the AHI or the
arousal index.
Materials and methods
Participants
The study population consisted of 29,258 persons (aged
30–65 years, 50% female) of whom 16,302 (55.7%)
completed the BQ [22] (Fig. 1). Of them, 3,960 (24.3%)
were classified at risk of OSA according to the BQ scoring
algorithm [26], which defines three risk categories: (I)
snoring, (II) daytime somnolence, and (III) obesity or self-
reported hypertension (Table 1). Obesity was defined as a
body mass index (BMI) >30 kg/m2 calculated from self-
reported weight and height. High risk on the BQ was
defined as any combination of two or three of these
categories [26].
From the 3,960 BQ high-risk persons classified at risk
for OSA, 1,085 (27.4%) were randomly drawn and 852 of
them were asked to participate in the Akershus Sleep Apnea
Project (ASAP) for clinical investigations. Persons with
established cardiovascular disease, diabetes, or previous
otitis media surgery were oversampled. The reason that not
all 1,085 were asked to participate was that, after the
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predefined strata were saturated, the invitation process was
stopped. Altogether, 101 persons were not reached by
telephone after three attempts; 353 declined participation;
233 not approached, and 20 were excluded according to the
following exclusion criteria: use of continuous positive
airway pressure (n=10), pregnancy (n=4), inadequate
Norwegian language skills (n=4), and severe physical
impairment as defined by inability to walk the stairs of
our sleep laboratory (n=2). This recruitment procedure
resulted in 378 participants which was 44.3% from 852.
The present sample comprises consecutive, BQ high-risk
persons included in the ASAP between 1 June 2006 and 31
March 2007. During this time, 654 persons had been
approached and 290 participants (44.3%) were included.
Measures
Cognitive function
The Rey Auditory Verbal Listening Test (RAVLT) [27] was
used to assess verbal memory. The RAVLT score, which is
the sum of words retrieved from hearing 15 common words
five times (range, 0–75), was calculated.
A shortened version of the Comali/Kaplan Stroop test
[28] was used to assess response inhibition, which is
regarded as a measure of executive function. The score
computed was Stroop interference time, the time used on a
task requiring response inhibition minus the average time
used to name 48 colored patches and to read 48 color
Study population, n = 29,258
Responders = screening sample, n = 16,302
(3,960 high-risk, 12,342 low-risk)
Drawn BQ high-risk, n = 1,085
Included in the ASAP, n = 378
Participants = clinical sample, n = 290
Not responding, n= 12,956
Not invited, n = 233
Not reached, n = 101
Not interested, n = 353
Excluded, n = 20
Fig. 1 Diagram to show the flow of persons from the study population to
the final inclusion of participants
Screening
sample
Participants p
Value
n=3,960 n=290
Age in years, mean (SD) 48.8 (10.3) 48.2 (11.2) 0.357
Male gender, n (%) 2,198 (55.5) 162 (55.9) 0.899
Higher education, n (%) 80 (28.1)
Body mass index, mean (SD) 29.1 (5.2) 29.0 (4.9) 0.951
Smoking, n (%) 89 (31.0)
Alcohol abuse, n (%) 5 (1.7)
Berlin Questionnaire
Snoring category, n (%) 3,654 (92.3) 264 (91.0) 0.412
Daytime somnolence category, n (%) 2,498 (63.1) 205 (70.7) 0.005
Hypertension/obesity category, n (%) 2,624 (66.3) 193 (66.6) 0.914
Sleepiness and comorbidities
Epworth Sleepiness Scale, mean (SD) 8.8 (4.5) 9.5 (4.2) <0.001
Excessive daytime sleepiness, n (%) 1,336 (33.7) 117 (40.9) <0.001
Self-reported asthma, n (%) 597 (16.5) 50.0 (18.8) 0.289
Polysomnography indices
AHI, median (25th and 75th percentiles) 7.7 (2.4, 22.2)
Arousal index, mean (SD) 19.9 (15.9)
Nadir oxygen saturation, median (25th and 75th
percentiles)
86.0 (82.0, 89.0)
Average oxygen saturation, mean (SD) 94.3 (2.0)
Relevant standard blood tests
Blood hemoglobina, mean (SD) 15.1 (1.2)
Serum ferritinb, mean (SD) 121.5 (96.0)
Table 1 Description of
the screening sample and
the clinical sample
AHI apnea–hypopnea index, SD
standard deviation
a Gram/deciliter
bMicrogram/liter
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names. Thus, a low score (seconds) indicates better
executive function.
All assessments were made by the first author (HHS)
before sleep registering.
Sleep recordings
Participants underwent in-hospital polysomnography,
including two-channel electroencephalography (C4/A1 and
C3/A2), two-channel electrooculography, one-channel sub-
mental electromyography, leg electromyography (tibialis),
measurement of oxygen saturation by finger plethysmography
(Nonin, Plymouth, MN, USA), assessment of breathing
movements (Respitrace; Ambulatory Monitoring, Ardsley,
NY, USA), nasal and oral air flow assessment (Protech,
Woodinville, WA, USA), and body position monitoring. All
electrophysiological signals were preamplified, stored and
subsequently scored at 30-s epochs using the Somnologica 3.2
software package (Flaga-Medcare, Buffalo, NY, USA) in
accordance with the Rechtshaffen and Kales scoring manual
[29] by two US board-certified polysomnography technicians
who were blinded to the result of the BQ. Apneas were
scored when airflow dropped below 10% of the reference
amplitude for more than 10 s. Hypopneas were scored when
airflow dropped below 70% for more than 10 s with a
subsequent oxygen desaturation of 4%. Arousals were
documented and classified according to standard criteria
[30]. The AHI and arousal indices were calculated as the
sum of apneas plus hypopneas and the sum of arousals per
hours of sleep, respectively. The following variables of
oxygen saturation were registered: the 4% oxygen desatura-
tion index (4% ODI) [13], percent time <90% saturation [16,
20], nadir oxygen saturation [20], and average oxygen
saturation during sleep [21].
Demographic and clinical characteristics
Demographic data, BQ categories, sleepiness, and medical
comorbidities were reported in the screening questionnaire
3–11 months prior to the overnight stay (Table 1).
Educational level and smoking were reported during the
overnight stay. Higher education was defined as having any
college or university degree. A dichotomous variable of
current smoking was computed, based on reported daily
smoking. Missing information was replaced when possible
by answers to other items assessing smoking. Diagnoses of
alcohol abuse and/or dependency were determined by the
structured clinical interview for Diagnostic and Statistical
Manual for Mental Disorders [31] administered by the first
author after measurement of cognitive function. The
presence of asthma was assessed by self-report (yes/no) in
the screening questionnaire. Sleepiness was assessed by a
Norwegian translation of the Epworth Sleepiness Scale
(ESS) [32, 33]. Excessive daytime sleepiness (EDS) was
defined as a score >10 on the ESS. Blood hemoglobin and
serum ferritin were analyzed from blood samples obtained
in the morning after sleep registration.
Ethics
The study protocol was approved in 2005 by the Regional
Committee for Medical Research Ethics in Eastern Norway,
the National Data Inspectorate and the Norwegian Social
Science Data Services. All subjects provided written
consent before participating.
Statistical analyses
Differences between participants and nonparticipants
included in the screening sample were analyzed by
Student’s t test and Chi-square test for normally distributed
continuous variables and categorical variables, respectively.
The choice of categorization of measures of OSA severity in
tertiles was based on the distribution of the AHI with the upper
tertile close to the clinical cut-off between mild (AHI 5–14.9)
and moderate (AHI 15–29.9) OSA [34]. Differences in
cognitive scores between clinical cut-off values of the AHI
and these tertiles in other measures of OSA severity were
analyzed by one-way ANOVA with Bonferroni post hoc test.
Two-sided P values<0.05 were considered statistically signif-
icant. Comparisons of cognitive test results between groups of
putative confounders were performed with Student’s t test.
Standard multiple regression models adjusting for age, gender
and higher education were used to examine the effect of OSA
severity on test results. Because of missing information
regarding polysomnography data (n=1), oxygen saturation
data (n=2), higher education (n=5), RAVLT (n=4), and
Stroop test (n=2), the numbers of participants included in
multivariate analyses declined to a minimum of 281. Non-
normal variables assessing OSA severity were logarithmically
transformed. Standard models were finally adjusted by adding
putative confounders and strata variables one by one to these
basic models. If a 15% change in the coefficient of the
measure of OSA severity was observed, the variable was
included in the final model. Interaction analyses and analyses
of alternative distributions of measures of OSA severity were
performed. All statistical analyses were obtained by using the
Statistical Package for Social Sciences, version 16.0.
Results
Sociodemographic and clinical characteristics are displayed in
Table 1. There were no significant differences in age, gender,
snoring, obesity, or history of hypertension between the 290
participants and the 3,670 nonparticipants. However, a
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significantly higher proportion of participants than non-
participants were classified in the daytime somnolence
category (participants 70.7%, nonparticipants 62.5%), and in
the EDS category (participants 43.1%, nonparticipants
33.0%). Five persons fulfilled the diagnostic criteria for
alcohol abuse/dependency.
The mean RAVLT score and Stroop interference time
among all participants were 42.0 words retrieved (SD=8.9)
and 31.1 s (SD=12.7), respectively. Compared with
available norms [35, 36], the group performed 1.3 to 1.2
standard deviations below normal mean. Unadjusted mean
cognitive test scores by commonly used cut-points for the
AHI and tertiles of nadir- and average oxygen saturation are
displayed in Table 2. Participants with AHI ≥15 had
significantly longer mean interference times on the Stroop
test than participants without OSA (p=0.001). A similar
pattern with a significant loss of cognitive performance
among participants in the tertile with the most severe versus
mildest oxygen saturation was seen when categorized by
lowest mean nadir oxygen saturation (83.0–54.0) and mean
average oxygen saturation (93.8–81.8). Similar but less
discriminant patterns were seen for tertiles of the 4% ODI
and percent time <90% saturation (data not shown).
Cognitive test scores did not differ significantly between
tertiles of the arousal index (data not shown).
Bivariate differences in cognitive scores by putative
confounders are displayed in Table 3. Correlation coefficients
between the Stroop interference times and standard blood
samples were not significant. Correlation coefficients between
the RAVLT score and blood hemoglobin and serum ferritin
were –0.168 (p=0.005) and –0.120 (p=0.046), respectively.
The ESS was not significantly related to any of the cognitive
tests (data not shown).
The final multiple regression models for the RAVLT
score and Stroop interference time with average oxygen
saturation as the independent variable assessing OSA
severity are presented in Tables 4 and 5. Average oxygen
saturation was found to be independently related to the
RAVLT score but not to the Stroop test.
Neither logarithmically transformed AHI, nadir oxygen
saturation, nor 4% ODI were independently related to the
RAVLT score and the Stroop interference time (Online
Resource, Tables 1–4). Percent time <90% was not
independently related to the RAVLT score but to the Stroop
interference time when adjusted for age, gender, and higher
education (Online Resource, Tables 7–8). However, this
association disappeared when BMI or BQ risk categories
were added to the model.
Discussion
To our knowledge, this is the first study to describe verbal
memory and executive function in community-dwelling
Table 2 Unadjusted mean cognitive test scores by established cut-off values of the AHI or tertiles of nadir- and average oxygen saturation
Test Category 1 Category 2 Category 3
n (range) n (range) n (range) F testa Trend test
Mean±SD Mean±SD Mean±SD p Value p Value
AHI AHI AHI
111 (0.0–4.9) 70 (5.0–14.9) 104 (15.0–104.0)
RAVLT scoreb 43.2±8.2 41.8±9.4 40.7±9.3 0.109 0.036
Stroop interference timec 28.4±12.0* 30.5±11.5 34.5±13.6 0.001 <0.001
Upper tertile nadir O2 Mid tertile nadir O2 Lower tertile nadir O2
85 (95.0%–89.0%) 110 (88.0%–84.0%) 93 (83.0%–54.0%)
RAVLT scoreb 43.2±8.4* 42.9±8.2* 39.7±9.9 0.010 0.008
Stroop interference timec 29.2±12.5* 29.1±11.8* 35.5±13.0 <0.001 0.001
Upper tertile average O2 Mid tertile average O2 Low tertile average O2
97 (97.8%–95.3%) 93 (95.2%–93.9%) 98 (93.8%–81.8%)
RAVLT scoreb 45.5±8.9* 41.6±8.4 38.8±9.5) <0.001 <0.001
Stroop interference timec 27.2±9.7* 32.7±14.4 33.7±12.8) <0.001 <0.001
a Test for overall model fit
b Sum of trials 1–5
c Difference in seconds
*p<0.05 for post hoc tests between category 1 and the two other categories identified by Bonferroni post hoc tests
AHI apnea–hypopnea index, RAVLT Rey Auditory Verbal Learning Test
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adults at high risk of having OSA, as identified by the BQ.
Verbal memory was found to be independently related to
average oxygen saturation, while executive function was
not related to OSA severity. The AHI, which is the most
commonly used measure when assessing OSA severity, was
only related to cognitive function in bivariate analyses. The
arousal index was not related to cognitive function in any
analysis.
The recruitment of participants by the BQ in this study
resulted in a sample of participants with a relatively lowmedian
AHI of 7.7 (25th percentile=2.4, 75th percentile=22.2)
compared with clinical studies of OSA. However, more than
one third of the sample had an AHI of ≥15, which is the criteria
for moderate to severe OSA [34]. The cognitive function
scores among participants were considerably higher than that
reported in “mild cognitive impairment”, which is the mildest
clinical entity of impaired cognitive function [37]. However,
the mean age of participants in this study was considerably
lower than the mean age of patients with mild cognitive
impairment [37]. Thus, our study adds knowledge to
epidemiological factors associated with early cognitive
decline rather than being a study of cognitively impaired
subjects per se.
Studies in the last 5 years have confirmed that verbal
memory is particularly affected by OSA pathology [7, 8]. On
the other hand, the association between OSA and the
complex executive function may be spurious [8, 11, 17] and
potentially influenced by attention [5, 38]. Unfortunately, no
objective measures of attention were available in the ASAP.
Accordingly, the Stroop interference time test, which provides
adjustment for baseline speed [5], was chosen.
We have not identified any previous studies that have
reported test results from the RAVLT or the Comali/
Kaplan Stroop test in community-based OSA popula-
tions. We therefore compared the RAVLT score with
general population norms [35] and the Stroop interference
time with an available clinical sample [36]. Both results
indicate mildly impaired cognitive function. RAVLT
scores are equivalent with general population norms of
persons 20–30 years older than the actual age of
participants of the study [35].
The salient finding of the second aim of this study was
the support of our hypothesis that oxygen saturation, rather
than the AHI or the arousal index, was associated with
Number RAVLT p Value Number STROOP interference timeb p Value
scorea
Mean±SD Mean±SD
Gender
Male 161 39.8±9.1 <0.001 160 31.8±13.6 0.365
Female 125 44.6±8.0 128 30.5±11.7
Higher education
Yes 79 45.8±8.1 <0.001 80 28.9±11.4 0.088
No 203 40.6±8.8 203 31.7±13.0
Smoking
Yes 88 41.8±8.7 0.876 89 30.2±12.3 0.327
No 195 42.0±9.1 31.8±13.1
Self-reported asthma
Yes 48 42.1±9.9 0.905 49 33.7±14.9 0.134
No 214 42.2±8.7 216 30.6±12.5
Use of hypnosedatives
Yes 15 42.1±8.9 0.117 15 38.4±18.2 0.132
No 271 38.4±8.9 273 30.8±12.4
Table 3 RAVLT score
and Stroop interference time
according to cofactors
a Rey Auditory Verbal Learning
Test, sum of trials 1–5
b Difference in seconds
MI myocardial infarction
Table 4 Final model for RAVLT score fitted by age, gender,
education, average oxygen saturation, and covariates
n=281 (adjusted R2=0.199; p<0.001)a βb SEc p Value
Intercept −19.278 32.969 0.559
Gender (0=female, 1=male) −3.251 1.033 0.002
Aged −0.168 0.047 <0.001
Higher educatione 4.722 1.076 <0.001
Average oxygen saturation 0.721 0.320 0.025
Body mass index 0.066 0.106 0.535
a Results from multiple regression analysis. Inclusion of the variables
smoking, self-reported myocardial infarction, sleepiness, use of antide-
pressants, and use of hypnosedatives in the model did not affect the
relationship between any covariate on the dependent variables
b β is the unstandardized regression coefficient of the variable
c SE is the standard error of β
d Unit of age, 5 years
e College or university
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verbal learning and executive function after adjusting for
age, gender, higher education, and putative confounders.
Smoking, alcohol consumption, and subjective sleepiness
were not related to cognitive test scores and thus were not
putative confounders of the associations examined.
Regarding the AHI, the fact that cognitive test scores
differed significantly by tertiles of the AHI only in
bivariate analyses (Table 2) suggests that the association
between AHI and cognitive function was potentially
mediated by covariates included in the final multiple
regression analysis. On the other hand, this is unlikely
because the association between the AHI and both
cognitive test scores disappeared when age, gender, and
higher education, which are unlikely mediators of this
association, were adjusted for. Regarding potential effect
modification between the AHI and these covariates, no
interaction terms were significant when added, one pair at
a time, to the multivariate models of AHI and verbal
memory and executive function, respectively.
Regarding oxygen saturation, a novel finding in our
study was that average oxygen saturation, rather than the
commonly used variables, explained most of the variation in
cognitive function. The effect of average oxygen saturation
has, somewhat surprisingly, not been reported in any of the
eight identified previous community-based studies or studies
of mild OSA [12–17]. Studies of cognitive function in
clinical samples of moderate to severe OSA have reported a
similar level of average oxygen saturation as our study [7,
39, 40], and a recent study also found that average oxygen
saturation was an independent predictor of cognitive decline
in middle-aged adults with moderate to severe OSA [41].
This finding was age-dependent.
We believe that the lack of an association between the
arousal index and measures of cognitive function should
be understood in relation to our finding of an indepen-
dent association with oxygen saturation. Objective sleep
quality has traditionally been more strongly associated
with memory consolidation than hypoxia [42]. However,
regarding OSA, accumulating evidence from studies
applying neuroimaging techniques [43–45] and studies of
animal models [46, 47] indicates that intermittent hypoxia
is the most important cause of neural injury related to this
disorder over time.
Finally, it should be kept in mind that different variables
assessing intermittent hypoxia or oxygen saturation might be
related to other aspects of chronic disease than OSA, such as
the nonlinear oxygen dissociation curve, abdominal obesity
limiting the functional residual capacity, or other lung
diseases. It is therefore interesting that the relations between
average oxygen saturation and cognitive function were not
altered by the inclusion of blood hemoglobin and serum
ferritin in the multivariate models. Regarding obesity, BMI
only slightly altered the association between average oxygen
saturation and the cognitive test results. The multiple
regression model for Stroop interference time was adjusted
for potential confounding by self-reported asthma. Asthma
was not found to be related to the association between average
oxygen saturation and the RAVLT score.
In summary, the finding of an independent association
between oxygen saturation, rather than the AHI or the
arousal index, with early cognitive decline in participants
with high risk of OSA emphasizes that future studies
should specify variables of OSA severity prior to analysis.
Future studies should also include enough subjects to allow
adjustment for putative confounders. Regarding which
variables to assess, we argue that average oxygen saturation
and other variables assessed through the whole night (4%
ODI, percentage time below 90% saturation) should be
considered in community-based samples or studies of mild
OSA because of the advantage of being less vulnerable to
artifacts than, for example, the nadir oxygen saturation.
Strengths and limitations
The use of polysomnography to assess OSA severity in a large,
community-based sample is an obvious strength. However, the
use of only a single, hospital-based polysomnography
recording is a potential limitation of the study [48]. Therefore,
the possible first night effect could not be controlled for. It
remains unknown what, if any, effect it may have had on
indicators of OSA severity.
Another strength of the study is that cognitive tests were
performed by the same physician at identical time points the
day prior to the polysomnography. Both tests were suggested
by Decary et al. [2] for use in OSA patients, although the
Table 5 Model for Stroop interference time fitted by age, gender,
education, average oxygen saturation and covariates
n=282 (adjusted R2=0.223, p<0.001)a βb SEc p Value
Intercept 35.389 48.319 0.465
Gender (0=female, 1=male) 0.105 1.507 0.944
Aged 0.494 0.068 <0.001
Higher educatione −3.047 1.551 0.051
Average oxygen saturation −0.360 0.470 0.444
Body mass index 0.206 0.156 0.189
Self-reported asthma 2.331 1.857 0.211
a Results from multiple regression analysis. Inclusion of the variables
smoking, logAHI, myocardial infarction, sleepiness, use of antidepressants,
and use of hypnosedatives in the model did not affect the relationship
between any covariate on the dependent variables
b β is the unstandardized regression coefficient of the variable
c SE is the standard error of β
d Unit of age, 5 years
e College or university
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limited number of tests increased the probability of a type 2
statistical error (i.e., finding no association when the
association is truly present). The cognitive tests should
ideally have been performed after the sleep studies, but with
the chronic nature of OSA, we consider this to be only a
minor weakness.
Regarding potential limitations, the relatively low response,
and participation rates biased the sample towards including
participants with more daytime impairments. However, we
believe that this mechanism did not significantly affect our
findings because daytime impairments did not contribute to the
multivariate models displayed in Tables 4 and 5.
The multivariate models should ideally have been
adjusted for diagnosed asthma rather than self-reported
asthma and more putative confounders such as better
measures of attention [9] or inflammation [49]. However,
the statistical models in this study are adjusted for more
putative confounders than most previous community-
based studies of the relation between OSA and cognitive
function.
Finally, the cross-sectional design and the lack of a control
group were limitations to causal interpretations. The cross-
sectional design also limited us from including variables in the
multivariate models that assessed psychological distress
because it could not be determined whether psychological
distress would be a cause or a consequence of cognitive
impairment.
Conclusion
Verbal memory and executive function were mildly
impaired in community-dwelling adults at high risk of
OSA. The data supported the hypothesis that memory
decline in OSA, as measured by the RAVLT score, is more
strongly related to oxygen desaturation than the AHI or the
arousal index. Average oxygen saturation during sleep,
rather than traditional variables assessing oxygen saturation
related to OSA, was the variable that was most strongly
related to the RAVLT score. No independent relations were
found between executive function, as measured by the
Stroop interference time, and variables of OSA severity.
The effect of average oxygen saturation on cognitive
function should be explored in future studies.
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